Unnamed: 0,activity_comment,activity_id,assay_chembl_id,assay_description,assay_type,bao_endpoint,bao_format,bao_label,canonical_smiles,document_chembl_id,document_journal,document_year,molecule_chembl_id,molecule_pref_name,parent_molecule_chembl_id,potential_duplicate,qudt_units,record_id,relation,src_id,standard_flag,standard_relation,standard_type,standard_units,standard_value,target_chembl_id,target_organism,target_pref_name,target_tax_id,toid,type,units,uo_units,value
45000,,5222368,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC,ug ml-1,UO_0000274,0.25
45001,,5222380,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC,ug ml-1,UO_0000274,0.25
45002,,5222392,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.25,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC,ug ml-1,UO_0000274,0.25
45003,,5222483,CHEMBL1674471,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2017 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45004,,5222484,CHEMBL1674470,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Stanley isolate s2018 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45005,,5222485,CHEMBL1674469,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Corvallis isolate s2052 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45006,,5222486,CHEMBL1674468,Antimicrobial activity against qnrA-positive Salmonella enterica serovar Mbandaka isolate s2093 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.5
45007,,5222487,CHEMBL1674467,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2209 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45008,,5222488,CHEMBL1674466,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Virginia isolate s2219 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45009,,5222489,CHEMBL1674465,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2425 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,2.0
45010,,5222490,CHEMBL1674464,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Typhimurium isolate s2705 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,2.0
45011,,5222491,CHEMBL1674463,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Braenderup isolate s2856 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45012,,5222492,CHEMBL1674462,Antimicrobial activity against qnrS-positive Salmonella enterica serovar Montevideo isolate s2944 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,2.0
45013,,5222493,CHEMBL1674461,Antimicrobial activity against Salmonella enterica serovar Stanley isolate s2043 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45014,,5222494,CHEMBL1674340,Antimicrobial activity against Salmonella enterica serovar Corvallis isolate s2064 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45015,,5222495,CHEMBL1674339,Antimicrobial activity against Salmonella enterica serovar Mbandaka isolate s2159 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.125
45016,,5222496,CHEMBL1674338,Antimicrobial activity against Salmonella enterica serovar Montevideo isolate s2317 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332015,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45017,Not Determined,5222497,CHEMBL1674337,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate s2878 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332015,,1,0,,MIC,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,,,
45018,Not Determined,5222498,CHEMBL1674336,Antimicrobial activity against Salmonella enterica serovar Braenderup isolate s2906 harboring ParC QRDR mutant gene by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332015,,1,0,,MIC,,,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,,,
45019,Not Determined,5222499,CHEMBL1674335,Antimicrobial activity against Salmonella enterica serovar Typhimurium isolate SL1344 harboring wild type ParC gene by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671664,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1332015,,1,0,,MIC,,,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,,,
45020,,5222747,CHEMBL1674903,Antimicrobial activity against Bacteroides distasonis after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC90,ug ml-1,UO_0000274,16.0
45021,,5222757,CHEMBL1674901,Antimicrobial activity against Bacteroides caccae after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC90,ug ml-1,UO_0000274,16.0
45022,,5222767,CHEMBL1674899,Antimicrobial activity against Bacteroides thetaiotaomicron after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,16.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC90,ug ml-1,UO_0000274,16.0
45023,,5222777,CHEMBL1674907,Antimicrobial activity against Bacteroides ovatus after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC50,ug ml-1,UO_0000274,2.0
45024,,5222787,CHEMBL1674905,Antimicrobial activity against Bacteroides vulgatus after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC50,ug ml-1,UO_0000274,2.0
45025,,5222797,CHEMBL1674903,Antimicrobial activity against Bacteroides distasonis after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC50,ug ml-1,UO_0000274,2.0
45026,,5222807,CHEMBL1674901,Antimicrobial activity against Bacteroides caccae after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC50,ug ml-1,UO_0000274,2.0
45027,,5222817,CHEMBL1674899,Antimicrobial activity against Bacteroides thetaiotaomicron after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC50,ug ml-1,UO_0000274,2.0
45028,,5222827,CHEMBL1674897,Antimicrobial activity against Bacteroides fragilis after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC90,ug ml-1,UO_0000274,8.0
45029,,5222837,CHEMBL1674897,Antimicrobial activity against Bacteroides fragilis after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC50,ug ml-1,UO_0000274,0.5
45030,,5222849,CHEMBL1674929,Antimicrobial activity against Bacteroides ovatus assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,72.0,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,Activity,%,UO_0000187,72.0
45031,,5222859,CHEMBL1674927,Antimicrobial activity against Bacteroides vulgatus assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,18.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,Activity,%,UO_0000187,18.0
45032,,5222869,CHEMBL1674925,Antimicrobial activity against Bacteroides vulgatus assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,72.0,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,Activity,%,UO_0000187,72.0
45033,,5222879,CHEMBL1674923,Antimicrobial activity against Bacteroides distasonis assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,18.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,Activity,%,UO_0000187,18.0
45034,,5222889,CHEMBL1674921,Antimicrobial activity against Bacteroides distasonis assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,72.0,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,Activity,%,UO_0000187,72.0
45035,,5222899,CHEMBL1674919,Antimicrobial activity against Bacteroides caccae assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,18.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,Activity,%,UO_0000187,18.0
45036,,5222909,CHEMBL1674917,Antimicrobial activity against Bacteroides caccae assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,72.0,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,Activity,%,UO_0000187,72.0
45037,,5222919,CHEMBL1674915,Antimicrobial activity against Bacteroides thetaiotaomicron assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,18.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,Activity,%,UO_0000187,18.0
45038,,5222929,CHEMBL1674913,Antimicrobial activity against Bacteroides thetaiotaomicron assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,72.0,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,Activity,%,UO_0000187,72.0
45039,,5222939,CHEMBL1674911,Antimicrobial activity against Bacteroides fragilis assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,11.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,11.0
45040,,5222949,CHEMBL1674909,Antimicrobial activity against Bacteroides fragilis assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,84.0,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,Activity,%,UO_0000187,84.0
45041,,5222959,CHEMBL1674907,Antimicrobial activity against Bacteroides ovatus after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL612686,Bacteroides ovatus,Bacteroides ovatus,28116.0,,MIC,ug ml-1,UO_0000274,0.13
45042,,5222969,CHEMBL1674905,Antimicrobial activity against Bacteroides vulgatus after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL612287,Phocaeicola vulgatus,Phocaeicola vulgatus,821.0,,MIC,ug ml-1,UO_0000274,0.13
45043,,5222979,CHEMBL1674903,Antimicrobial activity against Bacteroides distasonis after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614413,Parabacteroides distasonis,Parabacteroides distasonis,823.0,,MIC,ug ml-1,UO_0000274,0.13
45044,,5222989,CHEMBL1674901,Antimicrobial activity against Bacteroides caccae after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614749,Bacteroides caccae,Bacteroides caccae,47678.0,,MIC,ug ml-1,UO_0000274,0.13
45045,,5222999,CHEMBL1674899,Antimicrobial activity against Bacteroides thetaiotaomicron after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.13,CHEMBL614412,Bacteroides thetaiotaomicron,Bacteroides thetaiotaomicron,818.0,,MIC,ug ml-1,UO_0000274,0.13
45046,,5223009,CHEMBL1674897,Antimicrobial activity against Bacteroides fragilis after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL614411,Bacteroides fragilis,Bacteroides fragilis,817.0,,MIC,ug ml-1,UO_0000274,0.25
45047,,5223028,CHEMBL1675906,Antimicrobial activity against Actinomyces odontolyticus after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45048,,5223038,CHEMBL1676631,Antimicrobial activity against Actinomyces odontolyticus assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,92.0
45049,,5223048,CHEMBL1676633,Antimicrobial activity against Actinomyces odontolyticus assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
45050,,5223058,CHEMBL1676635,Antimicrobial activity against Actinomyces israelii after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,MIC,ug ml-1,UO_0000274,0.06
45051,,5223068,CHEMBL1676637,Antimicrobial activity against Actinomyces israelii assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,Activity,%,UO_0000187,92.0
45052,,5223078,CHEMBL1676639,Antimicrobial activity against Actinomyces israelii assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,Activity,%,UO_0000187,0.0
45053,,5223088,CHEMBL1676641,Antimicrobial activity against Actinomyces meyeri after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC,ug ml-1,UO_0000274,0.06
45054,,5223456,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC50,ug ml-1,UO_0000274,0.5
45055,,5223468,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC50,ug ml-1,UO_0000274,0.5
45056,,5223480,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC50,ug ml-1,UO_0000274,0.5
45057,,5223492,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC50,ug ml-1,UO_0000274,0.5
45058,,5223504,CHEMBL1674570,Antibacterial activity against Prevotella buccae by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,MIC90,ug ml-1,UO_0000274,8.0
45059,,5223516,CHEMBL1674571,Antibacterial activity against Prevotella bivia by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,MIC90,ug ml-1,UO_0000274,8.0
45060,,5223528,CHEMBL1674572,Antibacterial activity against Prevotella intermedia by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,MIC90,ug ml-1,UO_0000274,8.0
45061,,5223540,CHEMBL1674573,Antibacterial activity against Prevotella melaninogenica by by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,MIC90,ug ml-1,UO_0000274,8.0
45062,,5223575,CHEMBL1674706,Antibacterial activity against Prevotella buccae assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,75.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,Activity,%,UO_0000187,75.0
45063,,5223586,CHEMBL1674707,Antibacterial activity against Prevotella bivia assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,75.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,Activity,%,UO_0000187,75.0
45064,,5223597,CHEMBL1674708,Antibacterial activity against Prevotella intermedia assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,75.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,Activity,%,UO_0000187,75.0
45065,,5223608,CHEMBL1674709,Antibacterial activity against Prevotella melaninogenica assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,75.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,Activity,%,UO_0000187,75.0
45066,,5223619,CHEMBL1674710,Antibacterial activity against Prevotella buccae assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,19.0,CHEMBL612234,Prevotella buccae,Prevotella buccae,28126.0,,Activity,%,UO_0000187,19.0
45067,,5223630,CHEMBL1674711,Antibacterial activity against Prevotella bivia assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,19.0,CHEMBL612321,Prevotella bivia,Prevotella bivia,28125.0,,Activity,%,UO_0000187,19.0
45068,,5223641,CHEMBL1674712,Antibacterial activity against Prevotella intermedia assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,19.0,CHEMBL613261,Prevotella intermedia,Prevotella intermedia,28131.0,,Activity,%,UO_0000187,19.0
45069,,5223652,CHEMBL1674713,Antibacterial activity against Prevotella melaninogenica assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,19.0,CHEMBL612236,Prevotella melaninogenica,Prevotella melaninogenica,28132.0,,Activity,%,UO_0000187,19.0
45070,,5223680,CHEMBL1674730,Antibacterial activity against Veillonella parvula by by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612244,Veillonella parvula,Veillonella parvula,29466.0,,MIC,ug ml-1,UO_0000274,0.06
45071,,5223694,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC,ug ml-1,UO_0000274,0.03
45072,,5223706,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC,ug ml-1,UO_0000274,0.03
45073,,5223718,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC,ug ml-1,UO_0000274,0.03
45074,,5223730,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC,ug ml-1,UO_0000274,0.03
45075,,5223750,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC50,ug ml-1,UO_0000274,0.5
45076,,5223762,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC50,ug ml-1,UO_0000274,0.5
45077,,5223774,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC50,ug ml-1,UO_0000274,0.5
45078,,5223786,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.5,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC50,ug ml-1,UO_0000274,0.5
45079,,5224148,CHEMBL1676643,Antimicrobial activity against Actinomyces meyeri assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,Activity,%,UO_0000187,92.0
45080,,5224158,CHEMBL1676645,Antimicrobial activity against Actinomyces meyeri assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,Activity,%,UO_0000187,0.0
45081,,5224168,CHEMBL1676647,Antimicrobial activity against Actinomyces naeslundii after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC,ug ml-1,UO_0000274,0.06
45082,,5224178,CHEMBL1676649,Antimicrobial activity against Actinomyces naeslundii assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,Activity,%,UO_0000187,92.0
45083,,5224188,CHEMBL1676651,Antimicrobial activity against Actinomyces naeslundii assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,Activity,%,UO_0000187,0.0
45084,,5224198,CHEMBL1676653,Antimicrobial activity against Bifidobacterium adolescentis after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45085,,5224208,CHEMBL1676655,Antimicrobial activity against Bifidobacterium adolescentis assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,92.0
45086,,5224217,CHEMBL1676657,Antimicrobial activity against Bifidobacterium adolescentis assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,15.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,15.0
45087,,5224227,CHEMBL1676773,Antimicrobial activity against Bifidobacterium sp. after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.06
45088,,5224237,CHEMBL1676775,Antimicrobial activity against Bifidobacterium sp. assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,92.0
45089,,5224247,CHEMBL1676777,Antimicrobial activity against Bifidobacterium sp. assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,Activity,%,UO_0000187,0.0
45090,,5224257,CHEMBL1676779,Antimicrobial activity against Eubacterium lentum after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC,ug ml-1,UO_0000274,0.06
45091,,5224267,CHEMBL1676781,Antimicrobial activity against Eubacterium lentum assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,Activity,%,UO_0000187,92.0
45092,,5224277,CHEMBL1676783,Antimicrobial activity against Eubacterium lentum assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,Activity,%,UO_0000187,0.0
45093,,5224287,CHEMBL1676785,Antimicrobial activity against Eubacterium sp. after 48 hrs by agar dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL4888470,Eubacterium sp.,Eubacterium sp.,142586.0,,MIC,ug ml-1,UO_0000274,0.06
45094,,5224297,CHEMBL1676787,Antimicrobial activity against Eubacterium sp. assessed as percent susceptible isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,92.0,CHEMBL4888470,Eubacterium sp.,Eubacterium sp.,142586.0,,Activity,%,UO_0000187,92.0
45095,,5224307,CHEMBL1676789,Antimicrobial activity against Eubacterium sp. assessed as percent resistant isolates after 48 hrs by agar dilution method,F,BAO_0001103,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332372,=,1,0,=,Activity,%,0.0,CHEMBL4888470,Eubacterium sp.,Eubacterium sp.,142586.0,,Activity,%,UO_0000187,0.0
45096,,5224319,CHEMBL1675906,Antimicrobial activity against Actinomyces odontolyticus after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1.0
45097,,5224329,CHEMBL1676635,Antimicrobial activity against Actinomyces israelii after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,MIC50,ug ml-1,UO_0000274,1.0
45098,,5224339,CHEMBL1676641,Antimicrobial activity against Actinomyces meyeri after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC50,ug ml-1,UO_0000274,1.0
45099,,5224349,CHEMBL1676647,Antimicrobial activity against Actinomyces naeslundii after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC50,ug ml-1,UO_0000274,1.0
45100,,5224359,CHEMBL1676653,Antimicrobial activity against Bifidobacterium adolescentis after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1.0
45101,,5224369,CHEMBL1676773,Antimicrobial activity against Bifidobacterium sp. after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC50,ug ml-1,UO_0000274,1.0
45102,,5224379,CHEMBL1676779,Antimicrobial activity against Eubacterium lentum after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC50,ug ml-1,UO_0000274,1.0
45103,,5224389,CHEMBL1676785,Antimicrobial activity against Eubacterium sp. after 48 hrs by agar dilution method,F,BAO_0003035,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC50,ug.mL-1,1.0,CHEMBL4888470,Eubacterium sp.,Eubacterium sp.,142586.0,,MIC50,ug ml-1,UO_0000274,1.0
45104,,5224399,CHEMBL1675906,Antimicrobial activity against Actinomyces odontolyticus after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
45105,,5224409,CHEMBL1676635,Antimicrobial activity against Actinomyces israelii after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614976,Actinomyces israelii,Actinomyces israelii,1659.0,,MIC90,ug ml-1,UO_0000274,2.0
45106,,5224419,CHEMBL1676641,Antimicrobial activity against Actinomyces meyeri after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612289,Schaalia meyeri,Schaalia meyeri,52773.0,,MIC90,ug ml-1,UO_0000274,2.0
45107,,5224429,CHEMBL1676647,Antimicrobial activity against Actinomyces naeslundii after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL614975,Actinomyces naeslundii,Actinomyces naeslundii,1655.0,,MIC90,ug ml-1,UO_0000274,2.0
45108,,5224439,CHEMBL1676653,Antimicrobial activity against Bifidobacterium adolescentis after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
45109,,5224449,CHEMBL1676773,Antimicrobial activity against Bifidobacterium sp. after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC90,ug ml-1,UO_0000274,2.0
45110,,5224459,CHEMBL1676779,Antimicrobial activity against Eubacterium lentum after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL612337,Eggerthella lenta,Eggerthella lenta,84112.0,,MIC90,ug ml-1,UO_0000274,2.0
45111,,5224469,CHEMBL1676785,Antimicrobial activity against Eubacterium sp. after 48 hrs by agar dilution method,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671716,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332372,=,1,1,=,MIC90,ug.mL-1,2.0,CHEMBL4888470,Eubacterium sp.,Eubacterium sp.,142586.0,,MIC90,ug ml-1,UO_0000274,2.0
45112,,5224861,CHEMBL1674733,Antibacterial activity against beta-lactamase producing Clostridium perfringens by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,MIC90,ug ml-1,UO_0000274,1.0
45113,,5224873,CHEMBL1674734,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,MIC90,ug ml-1,UO_0000274,1.0
45114,,5224885,CHEMBL1674735,Antibacterial activity against beta-lactamase producing Clostridium septicum by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,MIC90,ug ml-1,UO_0000274,1.0
45115,,5224897,CHEMBL1674736,Antibacterial activity against beta-lactamase producing Clostridium tertium by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,1.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,MIC90,ug ml-1,UO_0000274,1.0
45116,,5224915,CHEMBL1674745,Antibacterial activity against beta-lactamase producing Clostridium perfringens assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,93.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,%,UO_0000187,93.0
45117,,5224925,CHEMBL1674746,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,93.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,Activity,%,UO_0000187,93.0
45118,,5224935,CHEMBL1674747,Antibacterial activity against beta-lactamase producing Clostridium septicum assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,93.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,Activity,%,UO_0000187,93.0
45119,,5224945,CHEMBL1674858,Antibacterial activity against beta-lactamase producing Clostridium tertium assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,93.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,Activity,%,UO_0000187,93.0
45120,,5224955,CHEMBL1675514,Antibacterial activity against beta-lactamase producing Clostridium perfringens assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614967,Clostridium perfringens,Clostridium perfringens,1502.0,,Activity,%,UO_0000187,0.0
45121,,5224965,CHEMBL1675515,Antibacterial activity against beta-lactamase producing Clostridium paraputrificum assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL615027,Clostridium paraputrificum,Clostridium paraputrificum,29363.0,,Activity,%,UO_0000187,0.0
45122,,5224975,CHEMBL1675516,Antibacterial activity against beta-lactamase producing Clostridium septicum assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL614968,Clostridium septicum,Clostridium septicum,1504.0,,Activity,%,UO_0000187,0.0
45123,,5224985,CHEMBL1675517,Antibacterial activity against beta-lactamase producing Clostridium tertium assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,0.0,CHEMBL613074,Clostridium tertium,Clostridium tertium,1559.0,,Activity,%,UO_0000187,0.0
45124,,5225013,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC,ug ml-1,UO_0000274,0.03
45125,,5225027,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC50,ug ml-1,UO_0000274,0.25
45126,,5225041,CHEMBL1675645,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,MIC90,ug ml-1,UO_0000274,8.0
45127,,5225053,CHEMBL1675648,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,78.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,Activity,%,UO_0000187,78.0
45128,,5225063,CHEMBL1675649,Antibacterial activity against beta-lactamase producing Peptostreptococcus anaerobius assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,13.0,CHEMBL614420,Peptostreptococcus anaerobius,Peptostreptococcus anaerobius,1261.0,,Activity,%,UO_0000187,13.0
45129,,5225079,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC,ug ml-1,UO_0000274,0.03
45130,,5225091,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC50,ug ml-1,UO_0000274,0.25
45131,,5225103,CHEMBL1675654,Antibacterial activity against beta-lactamase producing Micromonas micros by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,MIC90,ug ml-1,UO_0000274,8.0
45132,,5225113,CHEMBL1675655,Antibacterial activity against beta-lactamase producing Micromonas micros assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,78.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,Activity,%,UO_0000187,78.0
45133,,5225123,CHEMBL1675656,Antibacterial activity against beta-lactamase producing Micromonas micros assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,13.0,CHEMBL612380,Parvimonas micra,Parvimonas micra,33033.0,,Activity,%,UO_0000187,13.0
45134,,5225145,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC,ug ml-1,UO_0000274,0.03
45135,,5225157,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC50,ug ml-1,UO_0000274,0.25
45136,,5225169,CHEMBL1675663,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,MIC90,ug ml-1,UO_0000274,8.0
45137,,5225179,CHEMBL1675664,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,78.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,Activity,%,UO_0000187,78.0
45138,,5225189,CHEMBL1675665,Antibacterial activity against beta-lactamase producing Peptoniphilus asaccharolyticus assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,13.0,CHEMBL614419,Peptoniphilus asaccharolyticus,Peptoniphilus asaccharolyticus,1258.0,,Activity,%,UO_0000187,13.0
45139,,5225346,CHEMBL1679526,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,4.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,4.9
45140,,5225347,CHEMBL1679525,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,1.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,1.2
45141,,5225349,CHEMBL1680860,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,92.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,92.0
45142,,5225354,CHEMBL1679664,Antibacterial activity against methicillin-resistant Staphylococcus aureus by CLSI M7-A7 broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332070,=,1,1,=,MIC50,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC50,ug ml-1,UO_0000274,8.0
45143,,5225366,CHEMBL1679794,Antibacterial activity against Enterobacteriaceae by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332070,>=,1,1,>=,MIC90,ug.mL-1,0.12,CHEMBL614436,Enterobacteriaceae,Enterobacteriaceae,543.0,,MIC90,ug ml-1,UO_0000274,0.12
45144,,5225367,CHEMBL1679795,Antibacterial activity against Pseudomonas aeruginosa by CLSI M7-A7 broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332070,>=,1,1,>=,MIC90,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC90,ug ml-1,UO_0000274,8.0
45145,,5225381,CHEMBL1679806,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,61.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,61.2
45146,,5225385,CHEMBL1679807,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,87.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,87.7
45147,,5225389,CHEMBL1679808,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,91.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.4
45148,,5225396,CHEMBL1679810,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,91.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,91.7
45149,,5225399,CHEMBL1679811,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,93.0
45150,,5225403,CHEMBL1679812,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.9,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,93.9
45151,,5225406,CHEMBL1679813,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,98.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,98.4
45152,,5225409,CHEMBL1679814,Antibacterial activity against methicillin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45153,,5225415,CHEMBL1679819,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,6.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,6.3
45154,,5225417,CHEMBL1679820,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,9.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,9.4
45155,,5225427,CHEMBL1679962,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,21.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,21.3
45156,,5225430,CHEMBL1679963,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,26.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,26.0
45157,,5225433,CHEMBL1679964,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,51.2,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,51.2
45158,,5225437,CHEMBL1679965,Antibacterial activity against methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45159,,5225445,CHEMBL1680838,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,67.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,67.0
45160,,5225448,CHEMBL1680839,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,96.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,96.1
45161,,5225450,CHEMBL1680840,Antibacterial activity against Levofloxacin-susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45162,,5225458,CHEMBL1680847,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,0.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,0.7
45163,,5225460,CHEMBL1680848,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,14.3,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,14.3
45164,,5225462,CHEMBL1680849,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,20.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,20.4
45165,,5225464,CHEMBL1680850,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,53.7,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,53.7
45166,,5225467,CHEMBL1680851,Antibacterial activity against non-levofloxacin susceptible Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45167,,5225472,CHEMBL1680855,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,20.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,20.0
45168,,5225474,CHEMBL1680856,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,32.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,32.0
45169,,5225484,CHEMBL1680861,Antibacterial activity against community-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45170,,5225490,CHEMBL1680865,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,3.0
45171,,5225498,CHEMBL1680971,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,7.1,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,7.1
45172,,5225501,CHEMBL1680972,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,39.4,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,39.4
45173,,5225505,CHEMBL1680973,Antibacterial activity against hospital-associated methicillin-resistant Staphylococcus aureus assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,%,UO_0000187,100.0
45174,,5225512,CHEMBL1680978,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,30.2,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,30.2
45175,,5225516,CHEMBL1680979,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,53.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,53.5
45176,,5225522,CHEMBL1680981,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,55.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,55.8
45177,,5225524,CHEMBL1680982,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,62.8,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,62.8
45178,,5225527,CHEMBL1679336,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,74.4,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,74.4
45179,,5225531,CHEMBL1679337,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,90.7,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,90.7
45180,,5225534,CHEMBL1679338,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,93.0
45181,,5225537,CHEMBL1679339,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
45182,,5225541,CHEMBL1679343,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,11.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,11.1
45183,,5225544,CHEMBL1679345,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,33.3,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,33.3
45184,,5225548,CHEMBL1679347,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,Activity,%,UO_0000187,100.0
45185,,5226338,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,>,1,1,>,MIC,ug.mL-1,0.03,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC,ug ml-1,UO_0000274,0.03
45186,,5226350,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC50,ug ml-1,UO_0000274,0.25
45187,,5226362,CHEMBL1675672,Antibacterial activity against beta-lactamase producing Finegoldia magna by CLSI agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331839,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,MIC90,ug ml-1,UO_0000274,8.0
45188,,5226372,CHEMBL1675673,Antibacterial activity against beta-lactamase producing Finegoldia magna assessed as susceptible isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,78.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,Activity,%,UO_0000187,78.0
45189,,5226382,CHEMBL1675674,Antibacterial activity against beta-lactamase producing Finegoldia magna assessed as resistant isolates by CLSI agar dilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671627,Antimicrob Agents Chemother,2008.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1331839,=,1,0,=,Activity,%,13.0,CHEMBL614615,Finegoldia magna,Finegoldia magna,1260.0,,Activity,%,UO_0000187,13.0
45190,,5226680,CHEMBL1679352,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,18.9,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,18.9
45191,,5226684,CHEMBL1679353,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,81.6,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,81.6
45192,,5226688,CHEMBL1679354,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,98.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,98.8
45193,,5226691,CHEMBL1679355,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,99.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.1
45194,,5226696,CHEMBL1679357,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,99.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.4
45195,,5226698,CHEMBL1679510,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,99.8,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,99.8
45196,,5226701,CHEMBL1679511,Antibacterial activity against Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
45197,,5226708,CHEMBL1679516,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,9.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,9.4
45198,,5226709,CHEMBL1679517,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,59.4,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,59.4
45199,,5226711,CHEMBL1679518,Antibacterial activity against penicillin-resistant Streptococcus pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
45200,,5226726,CHEMBL1679527,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,44.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,44.4
45201,,5226729,CHEMBL1679528,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,65.4,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,65.4
45202,,5226733,CHEMBL1679529,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,67.9,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,67.9
45203,,5226740,CHEMBL1679532,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,72.8,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,72.8
45204,,5226742,CHEMBL1679533,Antibacterial activity against Enterococcus faecalis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,Activity,%,UO_0000187,100.0
45205,,5226748,CHEMBL1680373,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,13.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,13.2
45206,,5226749,CHEMBL1680374,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,18.4,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,18.4
45207,,5226752,CHEMBL1680375,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,26.3,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,26.3
45208,,5226759,CHEMBL1680377,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,28.9,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,28.9
45209,,5226762,CHEMBL1680378,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,34.2,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,34.2
45210,,5226765,CHEMBL1680379,Antibacterial activity against Enterococcus faecium assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,Activity,%,UO_0000187,100.0
45211,,5226775,CHEMBL1680385,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,60.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,60.3
45212,,5226779,CHEMBL1680386,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,67.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,67.1
45213,,5226783,CHEMBL1680387,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,68.8,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,68.8
45214,,5226787,CHEMBL1680388,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,73.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,73.5
45215,,5226791,CHEMBL1680389,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,75.1,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,75.1
45216,,5226794,CHEMBL1680390,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,75.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,75.5
45217,,5226798,CHEMBL1680391,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,77.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,77.3
45218,,5226801,CHEMBL1680392,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,80.3,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,80.3
45219,,5226805,CHEMBL1680393,Antibacterial activity against Escherichia coli assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,%,UO_0000187,100.0
45220,,5226817,CHEMBL1680524,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,24.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,24.1
45221,,5226821,CHEMBL1680525,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,72.4,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,72.4
45222,,5226825,CHEMBL1680526,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,77.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,77.9
45223,,5226829,CHEMBL1680527,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,83.9,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,83.9
45224,,5226833,CHEMBL1680528,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,91.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,91.5
45225,,5226837,CHEMBL1680529,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,93.0
45226,,5226841,CHEMBL1680530,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,94.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,94.5
45227,,5226844,CHEMBL1680531,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,96.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,96.0
45228,,5226848,CHEMBL1680532,Antibacterial activity against Klebsiella pneumoniae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,Activity,%,UO_0000187,100.0
45229,,5226856,CHEMBL1680536,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,46.9,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,46.9
45230,,5226859,CHEMBL1680537,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.8,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,93.8
45231,,5226863,CHEMBL1680538,Antibacterial activity against Klebsiella oxytoca assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL614441,Klebsiella oxytoca,Klebsiella oxytoca,571.0,,Activity,%,UO_0000187,100.0
45232,,5226869,CHEMBL1680541,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,68.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,68.1
45233,,5226872,CHEMBL1680542,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,87.5,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,87.5
45234,,5226874,CHEMBL1680543,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,90.3,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,90.3
45235,,5226876,CHEMBL1680544,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,91.7,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,91.7
45236,,5226881,CHEMBL1680546,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.1,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,93.1
45237,,5226885,CHEMBL1681164,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,94.4,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,94.4
45238,,5226889,CHEMBL1679398,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,98.6,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,98.6
45239,,5226892,CHEMBL1679399,Antibacterial activity against Enterobacter cloacae assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL349,Enterobacter cloacae,Enterobacter cloacae,550.0,,Activity,%,UO_0000187,100.0
45240,,5226899,CHEMBL1679402,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,3.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,3.0
45241,,5226903,CHEMBL1679403,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,30.3,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,30.3
45242,,5226907,CHEMBL1679404,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,63.6,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,63.6
45243,,5226910,CHEMBL1679405,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,78.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,78.8
45244,,5226916,CHEMBL1679407,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,81.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,81.8
45245,,5226918,CHEMBL1679541,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,84.8,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,84.8
45246,,5226920,CHEMBL1679542,Antibacterial activity against Proteus mirabilis assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL614444,Proteus mirabilis,Proteus mirabilis,584.0,,Activity,%,UO_0000187,100.0
45247,,5226927,CHEMBL1679545,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,1.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,1.5
45248,,5226934,CHEMBL1679547,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,2.9,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,2.9
45249,,5226938,CHEMBL1679548,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,5.8,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,5.8
45250,,5226942,CHEMBL1679549,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,23.4,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,23.4
45251,,5226946,CHEMBL1679550,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,51.1,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,51.1
45252,,5226950,CHEMBL1679551,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,64.2,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,64.2
45253,,5226954,CHEMBL1679552,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,76.6,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,76.6
45254,,5226958,CHEMBL1679553,Antibacterial activity against Pseudomonas aeruginosa assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 16 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,Activity,%,UO_0000187,100.0
45255,,5226967,CHEMBL1679560,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,7.7,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,7.7
45256,,5226969,CHEMBL1679561,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,15.4,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,15.4
45257,,5226971,CHEMBL1679562,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,42.3,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,42.3
45258,,5226975,CHEMBL1679563,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 1 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,65.4,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,65.4
45259,,5226979,CHEMBL1679564,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 2 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,76.9,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,76.9
45260,,5226983,CHEMBL1679565,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,92.3,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,92.3
45261,,5226986,CHEMBL1679566,Antibacterial activity against Stenotrophomonas maltophilia assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 8 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,Activity,%,UO_0000187,100.0
45262,,5226993,CHEMBL1679570,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.06 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,40.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,40.0
45263,,5226997,CHEMBL1679571,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.12 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,80.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,80.0
45264,,5227001,CHEMBL1679572,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.25 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,86.7,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,86.7
45265,,5227005,CHEMBL1679704,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 0.5 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,93.3,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,93.3
45266,,5227010,CHEMBL1679706,Antibacterial activity against Acinetobacter baumannii assessed as percent cumulative susceptible isolates at minimum inhibitory concentration of 4 ug/ml by CLSI broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671676,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332070,=,1,0,=,Activity,%,100.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,Activity,%,UO_0000187,100.0
45267,,5229241,CHEMBL1679882,Ratio of MIC for Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene to MIC for Escherichia coli K-12 3-AG300,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
45268,Not Determined,5229244,CHEMBL1679881,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-N623S-Q624S mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45269,Not Determined,5229258,CHEMBL1679880,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-G616N mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45270,Not Determined,5229272,CHEMBL1679174,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-I626M mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45271,Not Determined,5229286,CHEMBL1679173,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-M626I mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45272,Not Determined,5229300,CHEMBL1679172,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-N616 mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45273,,5229325,CHEMBL1679171,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331918,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45274,,5229339,CHEMBL1679170,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring acrB::rpsLneo mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331918,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
45275,,5229353,CHEMBL1679169,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-F628F mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1331918,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45276,Not Determined,5229369,CHEMBL1679886,Antimicrobial activity against Escherichia coli K-12 3-AG300 harboring AcrB-615-628MexB-S623N mutant gene,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671642,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1331918,,1,0,,MIC,,,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,,,
45277,,5229663,CHEMBL1678266,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as resistant isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332116,=,1,0,=,Activity,%,0.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,0.0
45278,,5229682,CHEMBL1678264,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae assessed as susceptible isolates by broth microdilution method,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1332116,=,1,0,=,Activity,%,100.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,%,UO_0000187,100.0
45279,,5229690,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332116,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
45280,,5229708,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332116,<,1,1,<,MIC50,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,0.25
45281,,5229722,CHEMBL1678262,Antimicrobial activity against erythromycin-resistant Streptococcus pneumoniae by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1671681,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1332116,<,1,1,<,MIC90,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,0.25
45282,,5296299,CHEMBL1691259,Bacteriostatic activity against Escherichia coli K-12 DM4100,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338194,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.125
45283,,5296329,CHEMBL1691261,Ratio of LD99 for Escherichia coli K-12 DM4100 to MIC for Escherichia coli K-12 DM4100,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687807,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338194,=,1,0,=,Ratio,,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,4.0
45284,Not Active,5298616,CHEMBL1690575,Antimicrobial activity against Acinetobacter lwoffii isolate A expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45285,Not Active,5298617,CHEMBL1690576,Antimicrobial activity against Acinetobacter lwoffii isolate B expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45286,Not Active,5298618,CHEMBL1690577,Antimicrobial activity against Acinetobacter lwoffii isolate C expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45287,Not Active,5298619,CHEMBL1690578,Antimicrobial activity against Acinetobacter lwoffii isolate D expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45288,Not Active,5298620,CHEMBL1690579,Antimicrobial activity against Acinetobacter lwoffii isolate E expressing beta-lactamase OXA-164 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45289,Not Active,5298621,CHEMBL1690580,Antimicrobial activity against Acinetobacter lwoffii isolate F expressing beta-lactamase OXA-164 isolated from tracheostoma of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45290,Not Active,5298622,CHEMBL1690581,Antimicrobial activity against Acinetobacter lwoffii isolate G expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45291,Not Active,5298623,CHEMBL1690582,Antimicrobial activity against Acinetobacter lwoffii isolate H expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45292,Not Active,5298624,CHEMBL1690583,Antimicrobial activity against Acinetobacter lwoffii isolate I expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45293,Not Active,5298625,CHEMBL1690584,Antimicrobial activity against Acinetobacter lwoffii isolate J expressing beta-lactamase OXA-58 isolated from bedsore by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45294,Not Active,5298626,CHEMBL1690585,Antimicrobial activity against Acinetobacter lwoffii isolate K expressing beta-lactamase OXA-58 isolated from blood culture of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45295,Not Active,5298627,CHEMBL1690703,Antimicrobial activity against Acinetobacter lwoffii isolate L expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45296,Not Active,5298628,CHEMBL1690704,Antimicrobial activity against Acinetobacter lwoffii isolate M expressing beta-lactamase OXA-58 isolated from tracheal secretion of patient by vitek 2 system,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687815,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338413,,1,0,,MIC,,,CHEMBL613778,Acinetobacter lwoffii,Acinetobacter lwoffii,28090.0,,MIC,,,
45297,,5299409,CHEMBL1697384,Apparent permeability from apical to basolateral side of human Calu3 cells after 6 hrs,A,BAO_0002808,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687762,Antimicrob Agents Chemother,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337798,=,1,0,=,Papp,cm/s,8.86,CHEMBL612558,,ADMET,,,Papp,cm/s,,8.86
45298,,5304005,CHEMBL1695975,Drug excretion in urine of healthy human at 800 mg/kg,A,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1337281,=,1,0,=,Activity,%,20.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,20.0
45299,,5304006,CHEMBL1696461,Drug excretion in feces of healthy human at 800 mg/kg,A,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1337281,=,1,0,=,Activity,%,25.0,CHEMBL612558,,ADMET,,,Activity,%,UO_0000187,25.0
45300,,5304007,CHEMBL1695966,Antimicrobial activity against rifampicin-sensitive Mycobacterium tuberculosis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337281,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,mg/L,UO_0000274,0.25
45301,,5304008,CHEMBL1696462,"Ratio of Cmax in healthy human at 400 mg/kg, po administered as a single dose to MIC90 for Mycobacterium tuberculosis",F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337281,=,1,0,=,Ratio,,8.6,CHEMBL612545,,Unchecked,,,Ratio,,,8.6
45302,,5304009,CHEMBL1696463,Antimicrobial activity against Mycobacterium tuberculosis infected in patients with tuberculosis assessed as percentage of patients with negative culture after 4 weeks,F,BAO_0001103,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687721,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1337281,=,1,0,=,Activity,%,37.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,%,UO_0000187,37.0
45303,,5305434,CHEMBL1696168,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in absence of thymidine,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
45304,,5305446,CHEMBL1696169,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient at pH 7.4 after 48 hrs by broth microdilution method in presence of thymidine,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
45305,,5306486,CHEMBL1696170,Antibacterial activity against revertant Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
45306,,5306498,CHEMBL1696171,Antibacterial activity against normal phenotype Staphylococcus aureus at pH 7.4 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45307,,5306526,CHEMBL1696174,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU after 5 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10cfu,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,1.0
45308,,5306528,CHEMBL1696176,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU after 72 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10cfu,,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,1.0
45309,,5306536,CHEMBL1696166,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10cfu,,3.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,3.0
45310,Active,5306552,CHEMBL1696181,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level after 24 hrs in presence of thymidine,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,,1,0,,Activity,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,Activity,,,
45311,,5306570,CHEMBL1696177,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein at up to 10'5 times MIC after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10cfu,,-1.32,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,-1.32
45312,,5306582,CHEMBL1696178,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient infected in human THP-1 cells assessed as log reduction of intracellular CFU level per mg of protein after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10cfu,,2.49,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10cfu,,,2.49
45313,,5306594,CHEMBL1696179,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level at up to 10'5 times MIC after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,<,1,0,<,log10CFU/ml,,-4.5,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,-4.5
45314,,5306606,CHEMBL1696180,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth assessed as log reduction of extracellular CFU level after 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337313,=,1,0,=,log10CFU/ml,,3.01,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,log10CFU/ml,,,3.01
45315,,5306618,CHEMBL1696305,Antibacterial activity against Staphylococcus aureus SCV isolated from cystic fibrosis patient in cation-adjusted MH 2 broth at pH 5.5 after 48 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45316,,5306630,CHEMBL1696306,Antibacterial activity against normal phenotype Staphylococcus aureus in cation-adjusted MH 2 broth at pH 5.5 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687729,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337313,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45317,,5307455,CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
45318,,5307456,CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
45319,,5307457,CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
45320,,5307458,CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
45321,,5307459,CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
45322,,5307460,CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45323,,5307461,CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45324,,5307462,CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45325,,5307463,CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
45326,,5307464,CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45327,,5307465,CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45328,,5307466,CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
45329,,5307467,CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.25
45330,,5307468,CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45331,,5307469,CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45332,,5307470,CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45333,,5307471,CHEMBL1694346,Antibacterial activity against Escherichia coli ATCC 25922 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,2.0
45334,,5307472,CHEMBL1694347,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,8.0
45335,,5307473,CHEMBL1694348,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
45336,,5307474,CHEMBL1694527,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
45337,,5307475,CHEMBL1694528,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,4.0
45338,,5307476,CHEMBL1694624,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,16.0
45339,,5307477,CHEMBL1694625,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,32.0
45340,,5307478,CHEMBL1694626,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as mutant prevention concentration,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,Activity,ug ml-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Activity,ug ml-1,UO_0000274,32.0
45341,,5307479,CHEMBL1694627,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,250.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,250.0
45342,,5307480,CHEMBL1694628,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,32.0
45343,,5307481,CHEMBL1694629,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,16.0
45344,,5307482,CHEMBL1694630,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,8.0
45345,,5307483,CHEMBL1694631,Ratio of mutant prevention concentration to MIC for Escherichia coli ATCC 25922 harboring GyrA S83L mutant,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,66.7,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,66.7
45346,,5307484,CHEMBL1694632,Ratio of mutant prevention concentration to MIC for qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
45347,,5307485,CHEMBL1694633,Ratio of mutant prevention concentration to MIC for qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,64.0
45348,,5307486,CHEMBL1694634,Ratio of mutant prevention concentration to MIC for qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1338562,=,1,0,=,Ratio,,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Ratio,,,32.0
45349,,5307487,CHEMBL1694635,Antibacterial activity against Escherichia coli ATCC 25922 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,48.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,48.0
45350,,5307488,CHEMBL1694636,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45351,,5307489,CHEMBL1694637,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45352,,5307490,CHEMBL1694638,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45353,,5307491,CHEMBL1694639,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45354,,5307492,CHEMBL1694640,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45355,,5307493,CHEMBL1694641,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45356,,5307494,CHEMBL1694642,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as earliest time required to resistant colonies visible one step below mutant prevention concentration,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Hour,1338562,=,1,1,=,TIME,hr,24.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,Time,hr,UO_0000032,24.0
45357,,5307495,CHEMBL1694643,Antibacterial activity against Escherichia coli ATCC 25922 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
45358,,5307496,CHEMBL1694644,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45359,,5307497,CHEMBL1694646,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45360,,5307498,CHEMBL1694647,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45361,,5307499,CHEMBL1694648,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45362,,5307500,CHEMBL1694649,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45363,,5307501,CHEMBL1694650,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45364,,5307502,CHEMBL1694651,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 assessed as resistant colonies recovered one step below mutant prevention concentration,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45365,,5307503,CHEMBL1694333,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrA gene and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.015
45366,,5307504,CHEMBL1694334,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrB gene and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45367,,5307505,CHEMBL1694335,Antibacterial activity against Escherichia coli ATCC 25922 expressing qnrS gene and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,1.0
45368,,5307506,CHEMBL1694336,Antibacterial activity against Escherichia coli ATCC 25922 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
45369,,5307507,CHEMBL1694337,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.125,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.125
45370,,5307508,CHEMBL1694221,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45371,,5307509,CHEMBL1694220,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45372,,5307510,CHEMBL1694219,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring GyrA S83L mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,2.0
45373,,5307511,CHEMBL1694218,Antibacterial activity against Escherichia coli ATCC 25922 harboring ParC S80R mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.008
45374,,5307512,CHEMBL1694332,Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrA1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45375,,5307513,CHEMBL1694223,Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrB1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45376,,5307514,CHEMBL1694217,Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant and pBK-QnrS1 by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.5
45377,,5307515,CHEMBL1694338,Antibacterial activity against Escherichia coli ATCC 25922 harboring GyrA S83L mutant and ParC S80R mutant by broth microdilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,0.25
45378,,5307516,CHEMBL1694339,"Antibacterial activity against qnrA gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrA1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,4.0
45379,,5307517,CHEMBL1694340,"Antibacterial activity against qnrB gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrB1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,2.0
45380,,5307518,CHEMBL1694341,"Antibacterial activity against qnrS gene expressing Escherichia coli ATCC 25922 harboring ParC S80R mutant, ParC S80R mutant and pBK-QnrS1 by broth microdilution method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687848,Antimicrob Agents Chemother,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1338562,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,4.0
45381,,5312392,CHEMBL1695549,Antimicrobial activity against toxin and capsule gene-deficient Bacillus anthracis Sterne after 24 hrs by macrobroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1337737,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MIC,mg/L,UO_0000274,0.06
45382,,5312393,CHEMBL1695551,Antimicrobial activity against toxin and capsule gene-deficient Bacillus anthracis Sterne after 24 hrs by agar dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,MBC,mg/L,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,MBC,mg/L,,1.0
45383,,5312396,CHEMBL1695553,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,13.0,CHEMBL612558,,ADMET,,,CL,L/hr,,13.0
45384,,5312397,CHEMBL1695554,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,12.0,CHEMBL612558,,ADMET,,,CL,L/hr,,12.0
45385,,5312398,CHEMBL1695555,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.24
45386,,5312399,CHEMBL1695556,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.4,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.4
45387,,5312400,CHEMBL1695652,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.338,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.338
45388,,5312401,CHEMBL1695653,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.151,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.151
45389,,5312402,CHEMBL1695654,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.24
45390,,5312403,CHEMBL1695655,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.41,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.41
45391,,5312404,CHEMBL1695656,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.86,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.86
45392,,5312405,CHEMBL1695657,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,19.8,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,19.8
45393,,5312406,CHEMBL1695658,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.46,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.46
45394,,5312407,CHEMBL1695659,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.667,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.667
45395,,5312408,CHEMBL1695660,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.08,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.08
45396,,5312409,CHEMBL1695661,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.91
45397,,5312410,CHEMBL1695662,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,29.8,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,29.8
45398,,5312411,CHEMBL1695663,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,5.93,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,5.93
45399,,5312412,CHEMBL1695976,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.63,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.63
45400,,5312413,CHEMBL1695977,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.38,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.38
45401,,5312414,CHEMBL1695978,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,4.96,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,4.96
45402,,5312415,CHEMBL1695979,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.2,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.2
45403,,5312416,CHEMBL1695980,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.31,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.31
45404,,5312417,CHEMBL1695981,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.41,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.41
45405,,5312418,CHEMBL1695982,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,41200000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,41200000.0
45406,,5312419,CHEMBL1695983,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,38500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,38500000.0
45407,,5312420,CHEMBL1695984,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,169.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,169.0
45408,,5312421,CHEMBL1695985,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,99.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,99.0
45409,,5312422,CHEMBL1695986,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1740000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1740000.0
45410,,5312423,CHEMBL1695987,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1880000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1880000.0
45411,,5312424,CHEMBL1695988,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered for every 24 hrs,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,32.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,32.0
45412,,5312425,CHEMBL1695989,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model administered as continuous infusion,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,25.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,25.0
45413,,5312430,CHEMBL1695994,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,12.4,CHEMBL612558,,ADMET,,,CL,L/hr,,12.4
45414,,5312431,CHEMBL1696108,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,14.2,CHEMBL612558,,ADMET,,,CL,L/hr,,14.2
45415,,5312432,CHEMBL1696109,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,13.0,CHEMBL612558,,ADMET,,,CL,L/hr,,13.0
45416,,5312433,CHEMBL1696110,Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,13.3,CHEMBL612558,,ADMET,,,CL,L/hr,,13.3
45417,,5312434,CHEMBL1696111,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.26,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.26
45418,,5312435,CHEMBL1696112,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.25
45419,,5312436,CHEMBL1696113,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.25
45420,,5312437,CHEMBL1696114,Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.25,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.25
45421,,5312438,CHEMBL1696115,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.276,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.276
45422,,5312439,CHEMBL1696116,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.12,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.12
45423,,5312440,CHEMBL1696117,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.353,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.353
45424,,5312441,CHEMBL1696118,Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.339,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.339
45425,,5312442,CHEMBL1696119,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.28
45426,,5312443,CHEMBL1696120,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.28
45427,,5312444,CHEMBL1696121,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.28
45428,,5312445,CHEMBL1696122,Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.28,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.28
45429,,5312446,CHEMBL1696123,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,17.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,17.9
45430,,5312447,CHEMBL1696124,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,25.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,25.0
45431,,5312448,CHEMBL1696125,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,16.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,16.9
45432,,5312449,CHEMBL1696126,Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,8.07,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,8.07
45433,,5312450,CHEMBL1696127,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.246,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.246
45434,,5312451,CHEMBL1696128,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.315,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.315
45435,,5312452,CHEMBL1696129,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.462,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.462
45436,,5312453,CHEMBL1696130,Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.548,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.548
45437,,5312454,CHEMBL1696131,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.63,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.63
45438,,5312455,CHEMBL1696132,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.37,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.37
45439,,5312456,CHEMBL1696133,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.11,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.11
45440,,5312457,CHEMBL1696134,Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.08,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.08
45441,,5312458,CHEMBL1695581,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,20.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,20.9
45442,,5312459,CHEMBL1696663,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,30.0
45443,,5312460,CHEMBL1696664,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,30.0
45444,,5312461,CHEMBL1696665,Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,30.0
45445,,5312462,CHEMBL1696666,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.74,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.74
45446,,5312463,CHEMBL1696667,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.74,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.74
45447,,5312464,CHEMBL1696792,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.73,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.73
45448,,5312465,CHEMBL1696793,Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.73,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.73
45449,,5312466,CHEMBL1696794,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.17,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.17
45450,,5312467,CHEMBL1696795,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,4.94,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,4.94
45451,,5312468,CHEMBL1696796,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,5.3,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,5.3
45452,,5312469,CHEMBL1696797,Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,5.18,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,5.18
45453,,5312470,CHEMBL1696798,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,10.1,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,10.1
45454,,5312471,CHEMBL1696799,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,9.06,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,9.06
45455,,5312472,CHEMBL1696800,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.65,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.65
45456,,5312473,CHEMBL1696801,Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.23,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.23
45457,,5312474,CHEMBL1696802,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,20600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,20600000.0
45458,,5312475,CHEMBL1696803,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,23500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,23500000.0
45459,,5312476,CHEMBL1696804,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,20600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,20600000.0
45460,,5312477,CHEMBL1696805,Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,21600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,21600000.0
45461,,5312478,CHEMBL1696806,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,50.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,50.0
45462,,5312479,CHEMBL1696807,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,169.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,169.0
45463,,5312480,CHEMBL1696808,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,222.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,222.0
45464,,5312481,CHEMBL1696809,Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,80.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,80.0
45465,,5312482,CHEMBL1696810,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1860000.0
45466,,5312483,CHEMBL1696811,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1880000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1880000.0
45467,,5312484,CHEMBL1696812,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1870000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1870000.0
45468,,5312485,CHEMBL1696813,Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1860000.0
45469,,5312486,CHEMBL1696814,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,15.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,15.0
45470,,5312487,CHEMBL1696815,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,32.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,32.0
45471,,5312488,CHEMBL1696816,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,34.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,34.0
45472,,5312489,CHEMBL1696817,Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg administered as continuous infusion by Bayesian method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,22.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,22.0
45473,,5312495,CHEMBL1696927,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,12.1,CHEMBL612558,,ADMET,,,CL,L/hr,,12.1
45474,,5312496,CHEMBL1696928,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,10.8,CHEMBL612558,,ADMET,,,CL,L/hr,,10.8
45475,,5312497,CHEMBL1696929,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,11.1,CHEMBL612558,,ADMET,,,CL,L/hr,,11.1
45476,,5312498,CHEMBL1696930,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,12.7,CHEMBL612558,,ADMET,,,CL,L/hr,,12.7
45477,,5312499,CHEMBL1696931,"Clearance in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",A,BAO_0002759,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CL,L/hr,11.9,CHEMBL612558,,ADMET,,,CL,L/hr,,11.9
45478,,5312500,CHEMBL1696932,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,5.14,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,5.14
45479,,5312501,CHEMBL1696933,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.57,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.57
45480,,5313520,CHEMBL1696934,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.42,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.42
45481,,5313521,CHEMBL1696935,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.81,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.81
45482,,5313522,CHEMBL1696936,"Growth rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.31,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.31
45483,,5313523,CHEMBL1696937,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.478,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.478
45484,,5313524,CHEMBL1696308,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.82,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.82
45485,,5313525,CHEMBL1697447,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.0407,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.0407
45486,,5313526,CHEMBL1697448,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.152,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.152
45487,,5313527,CHEMBL1697449,"Growth rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.161,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.161
45488,,5313528,CHEMBL1697450,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.24,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.24
45489,,5313529,CHEMBL1697451,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.48,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.48
45490,,5313530,CHEMBL1697452,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.58,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.58
45491,,5313531,CHEMBL1697453,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,4.29,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,4.29
45492,,5313532,CHEMBL1697454,"Kill rate constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,4.48,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,4.48
45493,,5313533,CHEMBL1697455,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,20.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,20.0
45494,,5313534,CHEMBL1697456,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,13.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,13.9
45495,,5313535,CHEMBL1697457,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,19.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,19.9
45496,,5313536,CHEMBL1697458,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,20.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,20.0
45497,,5313537,CHEMBL1697459,"Kill rate constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,16.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,16.9
45498,,5313538,CHEMBL1697460,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.393,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.393
45499,,5313539,CHEMBL1697461,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.516,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.516
45500,,5313540,CHEMBL1697462,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.227,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.227
45501,,5313541,CHEMBL1697463,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.719,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.719
45502,,5313542,CHEMBL1697464,"Concentrations at which the kill rate is half-maximal for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.667,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.667
45503,,5313543,CHEMBL1697465,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.984,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.984
45504,,5313544,CHEMBL1697466,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.707,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.707
45505,,5313545,CHEMBL1697581,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.16,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.16
45506,,5313546,CHEMBL1697582,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.89,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.89
45507,,5313547,CHEMBL1697583,"Concentrations at which the kill rate is half-maximal for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.27,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.27
45508,,5313548,CHEMBL1697584,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,5.84,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,5.84
45509,,5313549,CHEMBL1697585,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,30.0
45510,,5313550,CHEMBL1697586,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,30.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,30.0
45511,,5313551,CHEMBL1697587,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.0
45512,,5313552,CHEMBL1697588,"Hill constant for compound-sensitive toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.0
45513,,5313553,CHEMBL1697589,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.77,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.77
45514,,5313554,CHEMBL1697590,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,16.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,16.0
45515,,5313555,CHEMBL1697591,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.6,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.6
45516,,5313556,CHEMBL1697592,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,6.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,6.91
45517,,5313557,CHEMBL1697593,"Hill constant for compound-resistant toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,7.29,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,7.29
45518,,5313558,CHEMBL1697594,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.0657,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.0657
45519,,5313559,CHEMBL1697595,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.38,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.38
45520,,5313560,CHEMBL1697596,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,0.0657,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,0.0657
45521,,5313561,CHEMBL1697597,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.09,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.09
45522,,5313562,CHEMBL1697598,"Growth rate constant of vegetative-phase cells going to spore phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.91
45523,,5313563,CHEMBL1697599,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.91,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.91
45524,,5313564,CHEMBL1697600,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,25.9,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,25.9
45525,,5313565,CHEMBL1697601,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,2.27,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,2.27
45526,,5313566,CHEMBL1697602,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.01,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.01
45527,,5313567,CHEMBL1697603,"Growth rate constant of spore-phase cells going to vegetative phase in toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,Activity,/hr,1.04,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,Activity,/hr,,1.04
45528,,5313568,CHEMBL1697604,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,19600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,19600000.0
45529,,5313569,CHEMBL1697605,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,28000000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,28000000.0
45530,,5313570,CHEMBL1697606,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,21500000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,21500000.0
45531,,5313571,CHEMBL1697607,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,53600000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,53600000.0
45532,,5313572,CHEMBL1697608,"Total sensitive organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,36000000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,36000000.0
45533,,5313573,CHEMBL1696990,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,677.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,677.0
45534,,5313574,CHEMBL1695582,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,71.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,71.0
45535,,5313575,CHEMBL1695583,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,629.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,629.0
45536,,5313576,CHEMBL1695584,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,96.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,96.0
45537,,5313577,CHEMBL1695585,"Total resistant organism counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,45.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,45.0
45538,,5313578,CHEMBL1695586,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1860000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1860000.0
45539,,5313579,CHEMBL1695587,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1900000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1900000.0
45540,,5313580,CHEMBL1695588,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,1890000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,1890000.0
45541,,5313581,CHEMBL1695589,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,2420000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,2420000.0
45542,,5313582,CHEMBL1695590,"Total spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,2360000.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,2360000.0
45543,,5313583,CHEMBL1695591,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 50 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,41.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,41.0
45544,,5313584,CHEMBL1695592,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 100 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,21.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,21.0
45545,,5313585,CHEMBL1695692,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 150 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,40.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,40.0
45546,,5313586,CHEMBL1695693,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 200 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,24.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,24.0
45547,,5313587,CHEMBL1695694,"Resistant spore counts of toxin and capsule gene-deficient Bacillus anthracis Sterne in hollow-fiber pharmacodynamic infection model at 250 mg, qd by Bayesian method",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1687748,Antimicrob Agents Chemother,2009.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1337737,=,1,0,=,CFU/ml,,15.0,CHEMBL613904,Bacillus anthracis,Bacillus anthracis,1392.0,,CFU/ml,,,15.0
45548,drug-induced liver injury reported,5317609,CHEMBL1697778,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",A,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1341395,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
45549,no drug-induced liver injury reported,5318560,CHEMBL1697779,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",A,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1341395,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
45550,no drug-induced liver injury reported,5319511,CHEMBL1697780,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",A,BAO_0000179,BAO_0000221,tissue-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1697731,Chem Res Toxicol,2010.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1341395,,1,0,,Hepatotoxicity,,,CHEMBL1697861,,Hepatotoxicity,,,Hepatotoxicity,,,
45551,,6159997,CHEMBL1764237,Antitubercular activity against Mycobacterium tuberculosis H37Rv by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1759873,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1412571,=,1,1,=,MIC,nM,290.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.29
45552,,6160042,CHEMBL1764238,Antitubercular activity against Mycobacterium tuberculosis H37Rv by LORA assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1759873,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1412571,=,1,1,=,MIC,nM,31100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,31.1
45553,,6172602,CHEMBL1767999,Antimicrobial activity against Bacillus cereus ATCC 11778 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.3,CHEMBL613070,Bacillus cereus,Bacillus cereus,1396.0,,MIC,ug ml-1,UO_0000274,0.3
45554,,6172611,CHEMBL1768000,Antimicrobial activity against Bacillus megaterium ATCC 19213 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.003,CHEMBL613071,Priestia megaterium,Priestia megaterium,1404.0,,MIC,ug ml-1,UO_0000274,0.003
45555,,6172620,CHEMBL1768001,Antimicrobial activity against Bacillus subtilis ATCC 6633 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.015
45556,,6172629,CHEMBL1768002,Antimicrobial activity against Bacillus thuringiensis var.kurstaki BGSC 4D1 by broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL3879801,,NON-PROTEIN TARGET,,,MIC,ug ml-1,UO_0000274,0.03
45557,,6172638,CHEMBL1768003,Antimicrobial activity against Staphylococcus aureus ATCC 6538 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
45558,,6172647,CHEMBL1768004,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 72 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.0
45559,,6172656,CHEMBL1768005,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus aureus isolate SAR 4790 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,50.0
45560,,6172665,CHEMBL1768006,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.07,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.07
45561,,6172674,CHEMBL1768007,Antimicrobial activity against quinilone-pencillin-resistant Staphylococcus epidermidis clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,50.0
45562,,6172683,CHEMBL1768008,Antimicrobial activity against Acinetobacter baumannii ATCC 19606 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.15,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,0.15
45563,,6172692,CHEMBL1768009,Antimicrobial activity against quinilone-pencillin-resistant Acinetobacter baumannii clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,50.0
45564,,6172701,CHEMBL1768010,Antimicrobial activity against Escherichia coli ATCC 8739 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
45565,,6172710,CHEMBL1768011,Antimicrobial activity against quinilone-pencillin-resistant Escherichia coli clinical isolate by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,50.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,50.0
45566,,6172719,CHEMBL1768012,Antimicrobial activity against Haemophilus influenzae ATCC 19418 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.03
45567,,6172728,CHEMBL1768013,Antimicrobial activity against Pseudomonas aeruginosa ATCC 9027 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,MIC,ug.mL-1,0.7,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.7
45568,,6172737,CHEMBL1768014,Antimicrobial activity against Saccharomyces cerevisiae ATCC 9763 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL361,Saccharomyces cerevisiae,Saccharomyces cerevisiae,4932.0,,MIC,ug ml-1,UO_0000274,100.0
45569,,6172747,CHEMBL1768015,Antimicrobial activity against Candida tropicalis ATCC 1369 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL612870,Candida tropicalis,Candida tropicalis,5482.0,,MIC,ug ml-1,UO_0000274,100.0
45570,,6173383,CHEMBL1768201,Antimicrobial activity against Aspergillus niger ATCC 6275 by broth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,>,1,1,>,MIC,ug.mL-1,100.0,CHEMBL358,Aspergillus niger,Aspergillus niger,5061.0,,MIC,ug ml-1,UO_0000274,100.0
45571,,6173389,CHEMBL1768202,Inhibition of Escherichia coli DNA gyrase assessed as reduction of DNA supercoiling activity using pBR322 DNA substrate after 30 mins by electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,IC50,ug.mL-1,0.85,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,0.85
45572,,6173393,CHEMBL1768203,Inhibition of Escherichia coli topoisomerase 4 assessed as decatenation of kDNA after 30 mins by electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1765022,Bioorg Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1418181,=,1,1,=,IC50,ug.mL-1,5.0,CHEMBL612545,,Unchecked,,,IC50,ug ml-1,UO_0000274,5.0
45573,,6184721,CHEMBL1775353,Antibacterial activity against Escherichia coli ATCC25922 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.03
45574,,6184798,CHEMBL1775350,Inhibition of wild-type Staphylococcus aureus topoisomerase 4-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,IC50,nM,1000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,1.0
45575,,6184805,CHEMBL1775351,Inhibition of wild-type Staphylococcus aureus DNA gyrase assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,IC50,nM,7700.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,7.7
45576,,6184812,CHEMBL1775357,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45577,,6184819,CHEMBL1775519,Inhibition of Staphylococcus aureus topoisomerase 4 Ser80Phe mutant-mediated decatenation of kDNA after 30 mins by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1421986,=,1,1,=,IC50,nM,11900.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,11.9
45578,,6184826,CHEMBL1775520,Inhibition of Staphylococcus aureus DNA gyrase Ser84Leu mutant assessed as inhibition of supercoiling of pBR322 DNA after 60 min by gel electrophoresis assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1421986,>,1,1,>,IC50,nM,200000.0,CHEMBL2424506,Staphylococcus aureus,DNA gyrase subunit A,1280.0,,IC50,uM,UO_0000065,200.0
45579,,6199659,CHEMBL1775348,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45580,,6199677,CHEMBL1775352,Antibacterial activity against methicillin- and quinolone-resistant Staphylococcus aureus ATCC700699 after 24 hrs by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1772978,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1421986,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45581,,6212923,CHEMBL1787728,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781930,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1427239,=,1,1,=,MIC,nM,470.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.47
45582,,6228614,CHEMBL1785786,Cytotoxicity against MDCK cells after 48 hrs by CPE assay,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1427623,=,1,1,=,CC50,nM,161000.0,CHEMBL614068,Canis lupus familiaris,MDCK,9615.0,,CC50,uM,UO_0000065,161.0
45583,,6229772,CHEMBL1785609,Antibacterial activity against 10'4 CFU Staphylococcus aureus ATCC 25923 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
45584,,6229773,CHEMBL1785610,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.125
45585,,6229774,CHEMBL1785772,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus aureus 08-1 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45586,,6229775,CHEMBL1785773,Antibacterial activity against 10'4 CFU methicillin-sensitive Staphylococcus epidermidis 09-6 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
45587,,6229776,CHEMBL1785774,Antibacterial activity against 10'4 CFU methicillin-resistant Staphylococcus epidermidis 09-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
45588,,6229777,CHEMBL1785775,Antibacterial activity against 10'4 CFU Streptococcus pneumoniae 08-4 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
45589,,6229778,CHEMBL1785776,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-10 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,1.0
45590,,6229779,CHEMBL1785777,Antibacterial activity against 10'4 CFU Enterococcus faecalis 08-12 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,2.0
45591,,6229780,CHEMBL1785778,Antibacterial activity against 10'4 CFU Enterococcus faecium 08-2 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
45592,,6229781,CHEMBL1785779,Antibacterial activity against 10'4 CFU Enterococcus faecium 06-7 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
45593,,6229782,CHEMBL1785780,Antibacterial activity against 10'4 CFU Escherichia coli ATCC 25922 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45594,,6229783,CHEMBL1785781,Antibacterial activity against 10'4 CFU Escherichia coli 08-21 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45595,,6229784,CHEMBL1785782,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-22 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
45596,,6229785,CHEMBL1785783,Antibacterial activity against 10'4 CFU Klebsiella pneumoniae 09-23 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
45597,,6229786,CHEMBL1785784,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa ATCC 27853 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45598,,6229787,CHEMBL1785785,Antibacterial activity against 10'4 CFU Pseudomonas aeruginosa 09-32 after 18 hrs by CLSI agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1781961,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1427623,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.25
45599,,6258468,CHEMBL1798233,Antitubercular activity against replicating Mycobacterium tuberculosis H37Rv ATCC 27294 after 1 week by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1795314,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437546,=,1,1,=,MIC,ug.mL-1,0.83,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.83
45600,,6258479,CHEMBL1798148,Antitubercular activity against non-replicating Mycobacterium tuberculosis H37Rv ATCC 27294 incubated 10 days under anaerobic condition measured after 28 hrs of recovery in air by luciferase based low oxygen recovery assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1795314,Eur J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1437546,=,1,1,=,MIC,ug.mL-1,33.2,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,33.2
45601,,6300743,CHEMBL1811600,Antibacterial activity against Escherichia coli KD65,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,MIC,ug.mL-1,0.156,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.156
45602,,6300755,CHEMBL1811601,Antibacterial activity against tolC knockout Escherichia coli KD1397,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,MIC,ug.mL-1,0.004,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.004
45603,,6300767,CHEMBL1811602,Antibacterial activity against Mycobacterium smegmatis KD1163,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1806355,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1443962,=,1,1,=,MIC,ug.mL-1,0.08,CHEMBL613088,Mycolicibacterium smegmatis,Mycolicibacterium smegmatis,1772.0,,MIC,ug ml-1,UO_0000274,0.08
45604,,7849142,CHEMBL1914224,Antimicrobial activity against replicating Mycobacterium tuberculosis after 8 days by micro plate alamar blue assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1909569,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1543706,=,1,1,=,MIC90,nM,640.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,0.64
45605,,7849175,CHEMBL1914225,Antimicrobial activity against non-replicating Mycobacterium tuberculosis after 11 days by luminescence based low oxygen recovery assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1909569,Bioorg Med Chem Lett,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1543706,=,1,1,=,MIC90,nM,4300.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,4.3
45606,,7975772,CHEMBL1929933,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45607,,7975773,CHEMBL1929934,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45608,,7975774,CHEMBL1929935,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45609,,7975775,CHEMBL1929936,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45610,,7975776,CHEMBL1929937,Antibacterial activity against methicillin-resistant Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45611,,7975777,CHEMBL1929938,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45612,,7975778,CHEMBL1931190,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45613,,7975779,CHEMBL1931191,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45614,,7975780,CHEMBL1931192,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45615,,7975781,CHEMBL1931193,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-5 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.03
45616,,7975782,CHEMBL1931194,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 10-6 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45617,,7975783,CHEMBL1931195,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.5
45618,,7975784,CHEMBL1931196,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
45619,,7975785,CHEMBL1931197,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
45620,,7975786,CHEMBL1931198,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
45621,,7975787,CHEMBL1931199,Antibacterial activity against Streptococcus pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.008
45622,,7975788,CHEMBL1931200,Antibacterial activity against Enterococcus faecium 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
45623,,7975789,CHEMBL1931201,Antibacterial activity against Enterococcus faecium 09-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
45624,,7975790,CHEMBL1931202,Antibacterial activity against Enterococcus faecium 09-4 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.008
45625,,7975791,CHEMBL1931203,Antibacterial activity against Enterococcus faecium 09-5 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
45626,,7975792,CHEMBL1931204,Antibacterial activity against Enterococcus faecium 09-6 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.125
45627,,7975793,CHEMBL1931205,Antibacterial activity against Enterococcus faecalis 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
45628,,7975794,CHEMBL1931206,Antibacterial activity against Enterococcus faecalis 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
45629,,7975795,CHEMBL1931207,Antibacterial activity against Escherichia coli ATCC 25922 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
45630,,7975796,CHEMBL1931208,Antibacterial activity against Escherichia coli 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45631,,7975797,CHEMBL1931209,Antibacterial activity against Escherichia coli 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
45632,,7975798,CHEMBL1931287,Antibacterial activity against Escherichia coli 09-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45633,,7975799,CHEMBL1929633,Antibacterial activity against Escherichia coli 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45634,,7975800,CHEMBL1929634,Antibacterial activity against Escherichia coli 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45635,,7975801,CHEMBL1929635,Antibacterial activity against Escherichia coli 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,4.0
45636,,7975802,CHEMBL1929636,Antibacterial activity against Klebsiella pneumoniae 09-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
45637,,7975803,CHEMBL1929637,Antibacterial activity against Klebsiella pneumoniae 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
45638,,7975804,CHEMBL1929638,Antibacterial activity against Klebsiella pneumoniae 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
45639,,7975805,CHEMBL1929639,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45640,,7975806,CHEMBL1929640,Antibacterial activity against Pseudomonas aeruginosa 10-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.5
45641,,7975807,CHEMBL1929641,Antibacterial activity against Pseudomonas aeruginosa 10-2 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45642,,7975808,CHEMBL1929642,Antibacterial activity against Pseudomonas aeruginosa 10-3 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
45643,,7977060,CHEMBL1929863,Antibacterial activity against Enterococcus faecium 09-1 after 18 hrs by two fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1926550,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1563534,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
45644,,8017193,CHEMBL1948997,Antitubercular activity against Mycobacterium tuberculosis H37Rv after 16 to 24 hrs by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL1944533,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1576017,=,1,1,=,MIC,nM,500.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.5
45645,,10935888,CHEMBL2051639,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as minimum concentration required to inhibit 90% growth after 1 week by fluorescence-based microplate Alamar Blue assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1653724,=,1,1,=,MIC90,ug.mL-1,0.39,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,0.39
45646,,10935933,CHEMBL2051640,Antitubercular activity against non-replicating Mycobacterium tuberculosis assessed as minimum concentration required to inhibit 90% growth after 10 days under anaerobic condition by luciferase-based low-oxygen recovery assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1653724,=,1,1,=,MIC90,ug.mL-1,15.93,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,15.93
45647,Not Determined,10935941,CHEMBL2051641,Cytotoxicity against african green monkey Vero cells after 72 hrs by MTS assay,A,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2046299,Bioorg Med Chem Lett,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1653724,,1,0,,IC50,,,CHEMBL391,Chlorocebus sabaeus,Vero,60711.0,,IC50,,,
45648,,10936328,CHEMBL2049320,Antitubercular activity against Mycobacterium tuberculosis H37Rv in aerobic conditions after 7 days by microplate-based alamar blue assay,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2046330,J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1651821,=,1,1,=,MIC90,nM,460.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,0.46
45649,,10953145,CHEMBL2061991,Antibacterial activity against Escherichia coli ATCC 25922,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2057135,Bioorg Med Chem Lett,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658094,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.015
45650,,10953177,CHEMBL2061992,Antibacterial activity against Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2057135,Bioorg Med Chem Lett,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658094,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45651,,10979118,CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658369,=,1,1,=,MIC50,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC50,ug ml-1,UO_0000274,0.25
45652,,10979119,CHEMBL2066579,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolate after 18-24 hrs by two-fold serial dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2062435,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1658369,=,1,1,=,MIC90,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC90,ug ml-1,UO_0000274,8.0
45653,Not Determined,12070106,CHEMBL2162875,Cytotoxicity against human CHO cell line after 72 hrs,A,BAO_0000187,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1732872,,1,0,,CC50,,,CHEMBL613853,Cricetulus griseus,CHO,10029.0,,CC50,,,
45654,,12070117,CHEMBL2162874,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 5-FQR4M BSA678 expressing GyrA Ser84Leu and Ser85Pro mutant and GrlA Ser80Phe and Glu84Lys mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,64.0
45655,,12070128,CHEMBL2162873,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 4-FQR3M BSA643 expressing GyrA Ser84Leu mutant and GrlA Ser80Tyr and Glu84Gly mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
45656,,12070139,CHEMBL2162872,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 3-FQR3M ATCC 700699 expressing GyrA Ser84Leu mutant and Glu409Lys mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45657,,12070150,CHEMBL2162871,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 2-FQR2M NY2746 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45658,,12070161,CHEMBL2162870,Antibacterial activity against fluoroquinolone resistant Staphylococcus aureus 1-FQR2M BK2384 expressing GyrA Ser84Leu mutant and GrlA Ser80Phe mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45659,,12070193,CHEMBL2161980,Inhibition of Staphylococcus aureus topoisomerase 4 by decatenation assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1732872,=,1,1,=,IC50,nM,1000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,1.0
45660,,12070214,CHEMBL2161979,Inhibition of Staphylococcus aureus DNA gyrase by supercoiling assay,B,BAO_0000190,BAO_0000223,protein complex format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1732872,=,1,1,=,IC50,nM,18000.0,CHEMBL3038482,Staphylococcus aureus,DNA gyrase,1280.0,,IC50,uM,UO_0000065,18.0
45661,,12070235,CHEMBL2161978,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45662,,12070256,CHEMBL2161977,Antibacterial activity against methicillin-sensitive Staphylococcus aureus ATCC 29213,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2157972,J Med Chem,2011.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1732872,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45663,,12087012,CHEMBL2169387,Antimycobacterial activity against Mycobacterium tuberculosis clinical isolate,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2163329,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736139,=,1,1,=,MIC90,ug.mL-1,0.031,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,ug ml-1,UO_0000274,0.031
45664,,12087016,CHEMBL2169388,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2163329,Eur J Med Chem,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1736139,=,1,1,=,MIC,ug.mL-1,0.18,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.18
45665,,12398094,CHEMBL3061303,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3045173,Med Chem Res,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,1797769,=,1,1,=,MIC90,nM,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC90,uM,UO_0000065,0.25
45666,,12398106,CHEMBL3061303,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 7 days by MABA,F,BAO_0000201,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3045173,Med Chem Res,2012.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1797769,=,1,1,=,Inhibition,%,100.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,INH,%,UO_0000187,100.0
45667,,12532081,CHEMBL3077733,Antitubercular activity against Mycobacterium tuberculosis CSU93,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3046014,Med Chem Res,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1825956,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.25
45668,,12644213,CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC90,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC90,ug ml-1,UO_0000274,4.0
45669,,12644214,CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC80,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC80,ug ml-1,UO_0000274,4.0
45670,,12644215,CHEMBL2330398,Antibacterial activity against levofloxacin-intermediate and levofloxacin-resistant Streptococcus pneumoniae after 18 hrs by microbroth dilution method,F,BAO_0003035,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC50,ug.mL-1,2.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC50,ug ml-1,UO_0000274,2.0
45671,,12644216,CHEMBL2330399,Antibacterial activity against Chlamydophila pneumoniae CM-1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,MIC,ug ml-1,UO_0000274,0.125
45672,,12644217,CHEMBL2330400,Antibacterial activity against Chlamydophila pneumoniae AR39 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL612694,Chlamydia pneumoniae,Chlamydia pneumoniae,83558.0,,MIC,ug ml-1,UO_0000274,0.125
45673,,12644218,CHEMBL2330401,Antibacterial activity against Mycoplasma pneumoniae ATCC 29085 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.12
45674,,12644219,CHEMBL2330402,Antibacterial activity against Mycoplasma pneumoniae 18-1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612627,Mycoplasmoides pneumoniae,Mycoplasmoides pneumoniae,2104.0,,MIC,ug ml-1,UO_0000274,0.25
45675,,12644220,CHEMBL2330440,Antibacterial activity against Pseudomonas aeruginosa PAO1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,0.78
45676,,12644221,CHEMBL2330441,Antibacterial activity against Moraxella catarrhalis ATCC 25238 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL614429,Moraxella catarrhalis,Moraxella catarrhalis,480.0,,MIC,ug ml-1,UO_0000274,0.05
45677,,12644222,CHEMBL2330442,Antibacterial activity against Haemophilus influenzae ATCC 49247 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL355,Haemophilus influenzae,Haemophilus influenzae,727.0,,MIC,ug ml-1,UO_0000274,0.012
45678,,12644223,CHEMBL2330444,Antibacterial activity against Klebsiella pneumoniae TYPE1 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.1
45679,,12644224,CHEMBL2330443,Antibacterial activity against Escherichia coli NIHJ after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.012,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.012
45680,,12644225,CHEMBL2330445,Antibacterial activity against Bacillus subtilis IID 685 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL359,Bacillus subtilis,Bacillus subtilis,1423.0,,MIC,ug ml-1,UO_0000274,0.2
45681,,12644226,CHEMBL2330447,Antibacterial activity against Enterococcus faecalis ATCC 19433 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.2
45682,,12644227,CHEMBL2330446,Antibacterial activity against Streptococcus pyogenes G-36 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.2,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.2
45683,,12644228,CHEMBL2330448,"Antibacterial activity against quinolone, penicillin-resistant Streptococcus pneumoniae 104835 after 18 hrs by microbroth dilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,3.13,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,3.13
45684,,12644229,CHEMBL2330449,Antibacterial activity against penicillin-susceptible Streptococcus pneumoniae J24 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.1
45685,,12644230,CHEMBL2330450,Antibacterial activity against Staphylococcus epidermidis 56500 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.1,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.1
45686,,12644231,CHEMBL2330451,Antibacterial activity against levofloxacin-resistant and methicillin-resistant Staphylococcus aureus 870307 after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.78
45687,,12644232,CHEMBL2330452,Antibacterial activity against Staphylococcus aureus FDA 209-P after 18 hrs by microbroth dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2321831,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1853496,=,1,1,=,MIC,ug.mL-1,0.05,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.05
45688,,12712877,CHEMBL2344502,Inhibition of Mycobacterium leprae DNA gyrase GyrA/GyrB assessed as reduction of enzyme supercoiling activity using relaxed pBR322 DNA substrate incubated for 2 hrs at 30 degC by ethidium bromide based gel electrophoresis,B,BAO_0000190,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2331356,Bioorg Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,IC50,ug.mL-1,2.0,CHEMBL3301409,Mycobacterium leprae,Mycobacterium leprae,1769.0,,IC50,ug ml-1,UO_0000274,2.0
45689,,12712878,CHEMBL2344503,Inhibition of Mycobacterium tuberculosis DNA gyrase GyrA/GyrB assessed as reduction of enzyme supercoiling activity using relaxed pBR322 DNA substrate incubated for 1 hr at 37 degC by ethidium bromide based gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2331356,Bioorg Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,IC50,ug.mL-1,2.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,ug ml-1,UO_0000274,2.0
45690,,12712882,CHEMBL2344504,Antimicrobial activity against Mycobacterium tuberculosis H37Rv assessed as drug concentration causing =<1% reduction in bacterial growth incubated for 21 to 30 days by proportion method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2331356,Bioorg Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1873914,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
45691,,13373771,CHEMBL2406615,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45692,,13373796,CHEMBL2406616,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45693,,13373830,CHEMBL2406617,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45694,,13373858,CHEMBL2406618,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45695,,13373866,CHEMBL2406619,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,>,1,1,>,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
45696,,13373911,CHEMBL2406620,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45697,,13373933,CHEMBL2406621,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45698,,13375348,CHEMBL2406622,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2401670,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1904678,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45699,,13404379,CHEMBL2415954,fT>MIC in Mycobacterium tuberculosis infected mouse,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,1911950,=,1,0,=,fT>MIC,%,80.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fT>MIC,%,UO_0000187,80.0
45700,,13404381,CHEMBL2415956,fAUC/MIC in Mycobacterium tuberculosis infected mouse,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1911950,=,1,0,=,fAUC/MIC,,53.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,fAUC/MIC,,,53.0
45701,,13404382,CHEMBL2415955,AUC/MIC in Mycobacterium tuberculosis infected mouse,F,BAO_0000179,BAO_0000366,cell-free format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1911950,=,1,0,=,RatioAUC/MIC,,88.0,CHEMBL3879801,,NON-PROTEIN TARGET,,,RatioAUC/MIC,,,88.0
45702,,13404384,CHEMBL2415957,Cmax/MIC in Mycobacterium tuberculosis infected mouse,F,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL2412982,Bioorg Med Chem Lett,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1911950,=,1,0,=,Ratio,,17.0,CHEMBL612545,,Unchecked,,,Ratio,,,17.0
45703,,13825740,CHEMBL3089103,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA G96V mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3085704,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.12
45704,,13825745,CHEMBL3089104,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103L mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3085704,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.12
45705,,13825750,CHEMBL3089105,Antitubercular activity against Mycobacterium tuberculosis H37Rv expressing inhA M103I mutant assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3085704,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.12
45706,,13825780,CHEMBL3089492,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as parasite growth inhibition after 7 days by Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3085704,J Med Chem,2013.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1949273,=,1,1,=,MIC,ug.mL-1,0.12,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.12
45707,,13905233,CHEMBL3117232,Antimicrobial activity against quinolone-resistant Staphylococcus aureus clinical isolate 3519 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45708,,13905258,CHEMBL3117233,Antimicrobial activity against quinolone-resistant Staphylococcus aureus clinical isolate 3505 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45709,,13905283,CHEMBL3117234,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 3506 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45710,,13905308,CHEMBL3117235,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolate 3167 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45711,,13905331,CHEMBL3117236,Antimicrobial activity against Candida albicans 7535 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,0.5
45712,,13905354,CHEMBL3117237,Antimicrobial activity against Salmonella typhimurium 1926 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,1.0
45713,,13905377,CHEMBL3117238,Antimicrobial activity against Salmonella typhimurium 2421 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.5
45714,,13905400,CHEMBL3117239,Antimicrobial activity against Pseudomonas aeruginosa 2004 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45715,,13905423,CHEMBL3117240,Antimicrobial activity against Pseudomonas aeruginosa 2742 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45716,,13905446,CHEMBL3117241,Antimicrobial activity against Escherichia coli CCARM 1356 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
45717,,13905469,CHEMBL3117242,Antimicrobial activity against Escherichia coli KCTC 1924 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45718,,13906094,CHEMBL3117243,Antimicrobial activity against Streptococcus mutans 3065 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.25
45719,,13906117,CHEMBL3117244,Antimicrobial activity against Staphylococcus aureus 503 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45720,,13906140,CHEMBL3117245,Antimicrobial activity against Staphylococcus aureus 209 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45721,,13906163,CHEMBL3117246,Antimicrobial activity against Staphylococcus aureus RN4220 after 20 hrs by two-fold serial dilution technique,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3112479,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,1963702,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45722,,13948727,CHEMBL3131756,"Antitubercular activity against Mycobacterium tuberculosis H37Rv infected in C57BL/6 mouse assessed as reduction of bacterial CFU in lung at 30 mg/kg, po administered for 8 days measured 24 hrs post last dose relative to control",F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3124857,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1970563,=,1,0,=,FC,,3.48,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,3.48
45723,Active,13948739,CHEMBL3131768,Bactericidal activity against Mycobacterium tuberculosis H37Rv assessed as log reduction of bacterial CFU at 1.2 ug/mL after 1 week,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3124857,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,1970563,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
45724,,14591644,CHEMBL3240962,Antibacterial activity against 1 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2087679,=,1,1,=,MIC,nM,156.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.156
45725,,14591645,CHEMBL3240963,Antibacterial activity against 0.5 ug/ml Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2087679,=,1,1,=,MIC,nM,156.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.156
45726,,14591646,CHEMBL3241107,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 741 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.0625
45727,,14591647,CHEMBL3241108,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 753 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.0625
45728,,14591648,CHEMBL3241109,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 758 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.0625
45729,,14591649,CHEMBL3241110,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 760 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.0625
45730,,14591650,CHEMBL3241111,Antibacterial activity against drug-sensitive 1 ug/ml Mycobacterium tuberculosis clinical isolate 821 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
45731,,14591651,CHEMBL3241112,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 930 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
45732,,14591652,CHEMBL3241113,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1237 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.5
45733,,14591653,CHEMBL3240134,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1256 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,>,1,1,>,MIC,ug.mL-1,2.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,2.0
45734,,14591654,CHEMBL3240135,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1259 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
45735,,14591655,CHEMBL3240136,Antibacterial activity against multidrug-resistant 1 ug/ml Mycobacterium tuberculosis clinical isolate 1288 assessed as growth inhibition after 7 days by microtiter plate assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3232938,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2087679,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.125
45736,,14720237,CHEMBL3292117,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45737,,14720248,CHEMBL3292118,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 OE mutant assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45738,,14720259,CHEMBL3292119,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387S mutant assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45739,,14720270,CHEMBL3292120,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 C387G mutant assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45740,,14720281,CHEMBL3292121,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Y314H mutant assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45741,,14720292,CHEMBL3292122,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 harboring DprE1 Rv1937/F426C mutant assessed as growth inhibition after 5 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286390,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2113647,=,1,1,=,MIC,nM,125.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.125
45742,Not Active,14743707,CHEMBL3294046,Antimycobacterial activity against spontaneously resistant mutant of Mycobacterium tuberculosis H37Rv at 10 to 20 times MIC up to 6 to 8 weeks,F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2118300,,1,0,,Activity,,,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Activity,,,
45743,,14743732,CHEMBL3294029,Antimycobacterial activity against wild-type Mycobacterium tuberculosis H37Rv ATCC 27294 after 16 to 18 days by BACTEC 7H12B microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.06
45744,,14743748,CHEMBL3294030,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase holoenzyme-mediated supercoiling of pBR322 DNA after 90 mins by agarose gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2118300,=,1,1,=,IC50,nM,12500.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,12.5
45745,,14744146,CHEMBL3296295,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.15
45746,,14744297,CHEMBL3296315,Antimycobacterial activity against Mycobacterium tuberculosis over expressing DprE1 after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,80.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.08
45747,,14744305,CHEMBL3296316,Antimycobacterial activity against Mycobacterium tuberculosis over expressing InhA after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,160.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.16
45748,,14744313,CHEMBL3296317,Antimycobacterial activity against Mycobacterium tuberculosis over expressing TopA after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,310.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.31
45749,,14744321,CHEMBL3296318,Antimycobacterial activity against Mycobacterium tuberculosis over expressing PimA after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.15
45750,,14744332,CHEMBL3296319,Antimycobacterial activity against BTZ043-resistant Mycobacterium tuberculosis over expressing DprE1 C387S mutant after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,80.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.08
45751,,14744340,CHEMBL3296320,Antimycobacterial activity against TMC207R-resistant Mycobacterium tuberculosis clone 8.1 over expressing DprE1 mutant after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,150.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.15
45752,,14744348,CHEMBL3296321,Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis clone 4.1 over expressing DprE1 mutant after 5 days by standard microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286182,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2119187,=,1,1,=,MIC,nM,10000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,10.0
45753,Active,14745978,CHEMBL3294038,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase holoenzyme using pBR322 DNA as substrate assessed as linear DNA level at 0.02 to 11 uM after 60 mins by cleavable complex assay relative to control,B,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,2118300,,1,0,,Inhibition,%,,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,INH,,UO_0000187,
45754,,14746001,CHEMBL3291881,"Ratio of MIC for 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant to MIC for wild-type Mycobacterium tuberculosis H37Rv ATCC 27294",F,BAO_0000193,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2118300,=,1,0,=,Ratio,,16.0,CHEMBL612545,,Unchecked,,,Ratio,,,16.0
45755,,14746039,CHEMBL3291876,"Antimycobacterial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA A74V mutant",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.06
45756,,14746048,CHEMBL3291877,"Antimycobacterial activity against 5-(((3S,4R)-3-Fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile-resistant Mycobacterium tuberculosis harboring DNA gyraseA D89N mutant",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,1.0
45757,,14746057,CHEMBL3291878,Antimycobacterial activity against moxifloxacin-resistant Mycobacterium tuberculosis harboring DNA gyraseA G88N mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3286091,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2118300,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,4.0
45758,,15004906,CHEMBL3364655,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 as substrate after 30 mins by DNA supercoiling assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351599,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2268232,=,1,1,=,IC50,nM,11200.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,11.2
45759,,15004973,CHEMBL3364656,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351599,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2268232,=,1,1,=,MIC,nM,1200.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.2
45760,,15038109,CHEMBL3366298,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase A2B2 holoenzyme supercoiling activity using relaxed pBR322 substrate incubated for 90 mins by ethidium bromide staining based gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,IC50,nM,12500.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,12.5
45761,,15038126,CHEMBL3366299,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,MIC,nM,130.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.13
45762,,15038189,CHEMBL3366647,"Antimicrobial activity against 2-oxo-1-(2-(4-((3-oxo-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)methylamino)piperidin-1-yl)ethyl)-1,2-dihydroquinoline-7-carbonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase A74V mutant",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,MIC,nM,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.25
45763,,15038200,CHEMBL3366648,"Antimicrobial activity against 5-(((3S,4R)-3-fluoro-1-(2-(7-methoxy-2-oxo-1,5-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2-methylnicotinonitrile resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase D89N mutant",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,MIC,nM,2000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.0
45764,,15038211,CHEMBL3366649,Antimicrobial activity against moxicillin resistant Mycobacterium tuberculosis H37Rv ATCC 27294 containing DNA gyrase G88N mutant,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352071,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2255328,=,1,1,=,MIC,nM,4000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.0
45765,,15040526,CHEMBL3370006,Antimycobacterial activity against Mycobacterium abscessus ATCC 19977 in 7H9 medium after 3 days and 4 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,22400.0,CHEMBL612951,Mycobacteroides abscessus,Mycobacteroides abscessus,36809.0,,MIC,uM,UO_0000065,22.4
45766,,15040537,CHEMBL3370007,Antimycobacterial activity against Mycobacterium chelonae ATCC 35752 in 7H9 medium after 3 days and 4 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,240.0,CHEMBL612641,Mycobacteroides chelonae,Mycobacteroides chelonae,1774.0,,MIC,uM,UO_0000065,0.24
45767,,15040549,CHEMBL3370008,Antimycobacterial activity against Mycobacterium marinum ATCC 927 in 7H9 medium after 5 days and 6 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,12400.0,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,MIC,uM,UO_0000065,12.4
45768,,15040559,CHEMBL3370009,Antimycobacterial activity against Mycobacterium avium ATCC 15769 in 7H9 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,6100.0,CHEMBL614982,Mycobacterium avium,Mycobacterium avium,1764.0,,MIC,uM,UO_0000065,6.1
45769,,15040571,CHEMBL3370010,Antimycobacterial activity against Mycobacterium kansasii ATCC 12478 in 7H9 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,120.0,CHEMBL614984,Mycobacterium kansasii,Mycobacterium kansasii,1768.0,,MIC,uM,UO_0000065,0.12
45770,,15040581,CHEMBL3370011,Antimycobacterial activity against Mycobacterium bovis BCG ATCC 35734 in 7H12 medium after 6 days and 18 hrs after adding resazurin dye/Tween 80 by Microplate Alamar Blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352337,Bioorg Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2269590,=,1,1,=,MIC,nM,60.0,CHEMBL615052,Mycobacterium tuberculosis variant bovis BCG,Mycobacterium tuberculosis variant bovis BCG,33892.0,,MIC,uM,UO_0000065,0.06
45771,,15041236,CHEMBL3366088,Antimicrobial activity against first mutant generation Mycobacterium tuberculosis 1024_1 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,1.0
45772,,15041244,CHEMBL3366089,Antimicrobial activity against first mutant generation Mycobacterium tuberculosis 1024_18 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,1.0
45773,,15041253,CHEMBL3366090,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_18 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,0.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,0.5
45774,,15041261,CHEMBL3366091,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_8.12 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,1.0
45775,,15041269,CHEMBL3366092,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_16.5 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,1.0
45776,,15041277,CHEMBL3366093,Antimicrobial activity against second mutant generation Mycobacterium tuberculosis 1024_16.6 assessed as fold shift in MIC relative to parent strain,F,BAO_0000193,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351699,J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2255017,=,1,0,=,Ratio,,1.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,Ratio,,,1.0
45777,,15067026,CHEMBL3385759,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45778,,15067057,CHEMBL3385760,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-15 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
45779,,15067088,CHEMBL3385761,Antibacterial activity against Klebsiella pneumoniae 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.015
45780,,15067119,CHEMBL3385762,Antibacterial activity against Klebsiella pneumoniae 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.06
45781,,15067150,CHEMBL3385763,Antibacterial activity against Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.03
45782,,15067181,CHEMBL3385764,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
45783,,15067212,CHEMBL3385765,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
45784,,15067243,CHEMBL3385766,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-7 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.5
45785,,15067274,CHEMBL3385767,Antibacterial activity against extended-spectrum beta-lactamase producin Klebsiella pneumoniae 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
45786,,15067305,CHEMBL3385768,Antibacterial activity against Pseudomonas aeruginosa 12-12 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45787,,15071834,CHEMBL3385769,Antibacterial activity against Pseudomonas aeruginosa 12-14 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45788,,15071865,CHEMBL3385770,Antibacterial activity against Staphylococcus aureus ATCC 25923 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45789,,15071896,CHEMBL3385771,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
45790,,15071927,CHEMBL3385772,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45791,,15071958,CHEMBL3385773,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45792,,15071989,CHEMBL3385774,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.015
45793,,15072020,CHEMBL3385775,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45794,,15072051,CHEMBL3385776,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-4 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45795,,15072082,CHEMBL3385777,Antibacterial activity against methicillin-resistant Staphylococcus aureus 12-5 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45796,,15076602,CHEMBL3386333,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
45797,,15076633,CHEMBL3386334,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.125
45798,,15076664,CHEMBL3386335,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.03,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.03
45799,,15076695,CHEMBL3386336,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 12-8 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,1.0
45800,,15076726,CHEMBL3386337,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
45801,,15076757,CHEMBL3386338,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 12-6 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,16.0
45802,,15076788,CHEMBL3386339,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
45803,,15076819,CHEMBL3386340,Antibacterial activity against Streptococcus pneumoniae 12-18 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.5
45804,Not Determined,15079504,CHEMBL3364658,"Selectivity index, ratio of CC50 for mouse RAW264.7 cells to MIC for Mycobacterium tuberculosis H37Rv",T,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351599,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2268232,,1,0,,Selectivity Index,,,CHEMBL612545,,Unchecked,,,Selectivity Index,,,
45805,,15079547,CHEMBL3364659,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 as substrate at 0.97 uM after 30 mins by DNA supercoiling assay,B,BAO_0000201,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351599,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://qudt.org/vocab/unit#Percent,2268232,>,1,1,>,Inhibition,%,60.0,CHEMBL612545,,Unchecked,,,INH,%,UO_0000187,60.0
45806,,15105474,CHEMBL3386589,Inhibition of Mycobacterium tuberculosis DNA gyrase-mediated relaxed pBR322 DNA supercoiling by gel electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3351608,ACS Med Chem Lett,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2247307,=,1,1,=,IC50,nM,10000.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,10.0
45807,,15112914,CHEMBL3367585,Inhibition of Mycobacterium tuberculosis DNA gyrase supercoiling activity using relaxed pBR322 substrate incubated for 30 mins by ethidium bromide staining method,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352198,Bioorg Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2246975,=,1,1,=,IC50,nM,8100.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,8.1
45808,,15112946,CHEMBL3367584,Inhibition of 6-His-tagged Mycobacterium smegmatis GyrB expressed in Escherichia coli BL21 (DE3) pLysS cells incubated for 100 mins in presence of ATP by malachite green dye based ATP assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352198,Bioorg Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2246975,>,1,1,>,IC50,nM,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,IC50,uM,UO_0000065,50.0
45809,,15112980,CHEMBL3367586,Antibacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by microplate alamar blue assay method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352198,Bioorg Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2246975,=,1,1,=,MIC,nM,8600.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,8.6
45810,,15137969,CHEMBL3385755,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.008
45811,,15138000,CHEMBL3385756,Antibacterial activity against Escherichia coli 12-1 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45812,,15138031,CHEMBL3385757,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-2 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
45813,,15138062,CHEMBL3385758,Antibacterial activity against extended-spectrum beta-lactamase producing Escherichia coli 12-3 after 18 to 24 hrs by standard twofold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3352227,Eur J Med Chem,2014.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2272606,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,64.0
45814,,15180628,CHEMBL3405734,Inhibition of Mycobacterium smegmatis GyrB ATPase activity expressed in Escherichia coli BL21 (DE3) pLysS cells after 100 mins by inorganic phosphate release detection based malachite green reagent assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3399993,Bioorg Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2284758,>,1,1,>,IC50,nM,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,IC50,uM,UO_0000065,50.0
45815,,15180682,CHEMBL3405737,Inhibition of Mycobacterium tuberculosis GyrA/GyrB using relaxed pBR322 substrate incubated for 30 mins by ethidium bromide staining and electrophoresis based DNA supercoiling assay,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3399993,Bioorg Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2284758,=,1,1,=,IC50,nM,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,11.2
45816,,15181596,CHEMBL3405738,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microplate alamar blue assay method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3399993,Bioorg Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2284758,=,1,1,=,MIC,nM,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.26
45817,Not Active,15205215,CHEMBL3411493,Inhibition of Mycobacterium tuberculosis AlaDH using L-alanine as substrate after 20 mins by spectrophotometry,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3407436,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2289822,,1,0,,IC50,,,CHEMBL612545,,Unchecked,,,IC50,,,
45818,,15205244,CHEMBL3411505,Antimycobacterial activity against dormant Mycobacterium tuberculosis H37Rv model assessed as log reduction at 10 ug/ml incubated for 7 days measured after 28 days in presence of nutrient deprived condition,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3407436,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2289822,=,1,0,=,FC,,2.5,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,2.5
45819,,15205275,CHEMBL3411506,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by agar dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3407436,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2289822,=,1,1,=,MIC,nM,1240.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.24
45820,,15659326,CHEMBL3599454,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45821,,15659701,CHEMBL3599455,Antibacterial activity against Staphylococcus aureus KCTC 209 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45822,,15659732,CHEMBL3599456,Antibacterial activity against Staphylococcus aureus KCTC 503 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45823,,15659763,CHEMBL3599457,Antibacterial activity against Streptococcus mutans 3065 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.25
45824,,15659794,CHEMBL3599458,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45825,,15659825,CHEMBL3599459,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
45826,,15659856,CHEMBL3599460,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45827,,15659887,CHEMBL3599461,Antibacterial activity against Pseudomonas aeruginosa 2004 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45828,,15659918,CHEMBL3599462,Antibacterial activity against Salmonella typhimurium 2421 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.5
45829,,15659949,CHEMBL3599463,Antifungal activity against Candida albicans 7535 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,0.5
45830,,15659971,CHEMBL3599464,Bactericidal activity against Staphylococcus aureus RN4220 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,0.25
45831,,15660290,CHEMBL3599465,Bactericidal activity against Staphylococcus aureus KCTC 209 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.0
45832,,15660312,CHEMBL3599466,Bactericidal activity against Staphylococcus aureus KCTC 503 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,2.0
45833,,15660334,CHEMBL3599467,Bactericidal activity against Streptococcus mutans 3065 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MBC,ug ml-1,UO_0000274,0.25
45834,,15660356,CHEMBL3599468,Bactericidal activity against Escherichia coli KCTC 1924 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MBC,ug ml-1,UO_0000274,2.0
45835,,15660378,CHEMBL3599469,Fungicidal activity against Candida albicans 7535 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MFC,ug ml-1,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MFC,ug ml-1,UO_0000274,0.5
45836,,15660429,CHEMBL3599474,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45837,,15660460,CHEMBL3599475,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45838,,15660491,CHEMBL3599476,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45839,,15660522,CHEMBL3599591,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45840,,15660543,CHEMBL3599592,Bactericidal activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
45841,,15660564,CHEMBL3599593,Bactericidal activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,1.0
45842,,15660873,CHEMBL3599594,Bactericidal activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,4.0
45843,,15660894,CHEMBL3599595,Bactericidal activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by agar plate method,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3596093,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2489715,=,1,0,=,MBC,ug ml-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MBC,ug ml-1,UO_0000274,4.0
45844,,15689999,CHEMBL3610295,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 incubated for 7 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,MIC,nM,130.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.13
45845,,15690026,CHEMBL3610297,Inhibition of Mycobacterium tuberculosis H37Rv DNA gyrase assessed as supercoiling of pBR322 DNA after 90 mins by agarose gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,IC50,nM,12500.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,12.5
45846,,15690034,CHEMBL3610298,"Antimycobacterial activity against 6-((1-(2-(7-chloro-2-oxo-1,8-naphthyridin-1(2H)-yl)ethyl)piperidin-4-ylamino)methyl)-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA A74V mutant incubated for 7 days by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,MIC,nM,250.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,0.25
45847,,15690042,CHEMBL3610299,"Antimycobacterial activity against 1-(2-(4-((5-chloro-6-methylpyridin-3-yl)methylamino)piperidin-1-yl)ethyl)-7-fluoro-1,5-naphthyridin-2(1H)-one resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA D89N mutant incubated for 7 days by microdilution method",F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,MIC,nM,2000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.0
45848,,15690050,CHEMBL3610300,Antimycobacterial activity against moxifloxacin resistant Mycobacterium tuberculosis H37Rv harboring DNA gyraseA G88N mutant incubated for 7 days by microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608244,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2496835,=,1,1,=,MIC,nM,4000.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,4.0
45849,,15691789,CHEMBL3610234,Antimicrobial activity against Staphylococcus aureus ATCC 25923 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,0.0625,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.0625
45850,,15691806,CHEMBL3610235,Antimicrobial activity against methicillin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45851,,15691825,CHEMBL3610236,Antimicrobial activity against levofloxacin-resistant Staphylococcus aureus clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45852,,15691844,CHEMBL3610237,Antimicrobial activity against Streptococcus pneumoniae ATCC 49619 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
45853,,15691863,CHEMBL3610238,Antimicrobial activity against penicillin-resistant Streptococcus pneumoniae clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,0.125,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.125
45854,,15691882,CHEMBL3610239,Antimicrobial activity against Streptococcus pyogenes ATCC 19615 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL356,Streptococcus pyogenes,Streptococcus pyogenes,1314.0,,MIC,ug ml-1,UO_0000274,0.25
45855,,15691901,CHEMBL3610240,Antimicrobial activity against Staphylococcus epidermidis ATCC 12228 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,<=,1,1,<=,MIC,ug.mL-1,0.016,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.016
45856,,15691920,CHEMBL3610307,Antimicrobial activity against methicillin-resistant Staphylococcus epidermidis clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
45857,,15691939,CHEMBL3610308,Antimicrobial activity against Escherichia coli ATCC 25922 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,0.031,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.031
45858,,15691958,CHEMBL3610309,Antimicrobial activity against ciprofloxacin-resistant Escherichia coli clinical isolates by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
45859,,15691977,CHEMBL3610310,Antimicrobial activity against Pseudomonas aeruginosa ATCC 27853 by standard broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3608201,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2497975,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
45860,,15751109,CHEMBL3632234,Antibacterial activity against Staphylococcus aureus RN4220 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45861,,15751134,CHEMBL3632235,Antibacterial activity against Staphylococcus aureus 209 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45862,,15751170,CHEMBL3632236,Antibacterial activity against Staphylococcus aureus 503 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,2.0
45863,,15751200,CHEMBL3632237,Antibacterial activity against Streptococcus mutans 3065 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,0.25,CHEMBL612426,Streptococcus mutans,Streptococcus mutans,1309.0,,MIC,ug ml-1,UO_0000274,0.25
45864,,15751230,CHEMBL3632238,Antibacterial activity against Escherichia coli KCTC 1924 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45865,,15751553,CHEMBL3632239,Antibacterial activity against Escherichia coli CCARM 1356 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,128.0
45866,,15751583,CHEMBL3632240,Antibacterial activity against Pseudomonas aeruginosa 2742 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45867,,15751613,CHEMBL3632241,Antibacterial activity against Pseudomonas aeruginosa 2004 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45868,,15751643,CHEMBL3632242,Antibacterial activity against Salmonella typhimurium 2421 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL351,Salmonella enterica subsp. enterica serovar Typhimurium,Salmonella typhimurium,90371.0,,MIC,ug ml-1,UO_0000274,0.5
45869,,15751673,CHEMBL3632243,Antifungal activity against Candida albicans 7535 by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL366,Candida albicans,Candida albicans,5476.0,,MIC,ug ml-1,UO_0000274,0.5
45870,,15751701,CHEMBL3632244,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3167 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45871,,15751731,CHEMBL3632245,Antibacterial activity against methicillin-resistant Staphylococcus aureus CCARM 3506 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,1.0
45872,,15751761,CHEMBL3632246,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3505 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45873,,15751791,CHEMBL3632247,Antibacterial activity against quinolone-resistant Staphylococcus aureus CCARM 3519 after 24 hrs by two-fold serial dilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627681,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2508690,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45874,,15753249,CHEMBL3630322,Inhibition of DNA gyrase GyrA/GyrB in Mycobacterium tuberculosis incubated for 30 mins assessed as reduction in supercoiling of relaxed relaxed pBR322 DNA by ethidium bromide staining based agarose gel electrophoresis method,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627613,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2507504,=,1,1,=,IC50,nM,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,11.2
45875,,15753319,CHEMBL3630438,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv assessed as growth inhibition incubated for 7 days by microplate alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627613,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2507504,=,1,1,=,MIC,nM,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.26
45876,,15753729,CHEMBL3630319,Inhibition of Mycobacterium smegmatis DNA gyrase B expressed in Escherichia coli BL21 (DE3) pLysS cells assessed as reduction in ATPase activity incubated for 100 mins by inorganic phosphate detection assay,B,BAO_0000190,BAO_0000219,cell-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3627613,Eur J Med Chem,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2507504,>,1,1,>,IC50,nM,50000.0,CHEMBL3085613,Mycobacterium smegmatis,DNA gyrase subunit B,1772.0,,IC50,uM,UO_0000065,50.0
45877,,15763160,CHEMBL3637176,Antibacterial activity against Pseudomonas aeruginosa 14-14 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45878,,15763181,CHEMBL3637177,Antibacterial activity against Pseudomonas aeruginosa 14-15 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45879,,15763202,CHEMBL3637178,Antibacterial activity against Pseudomonas aeruginosa 14-16 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
45880,,15763223,CHEMBL3637179,Antibacterial activity against Pseudomonas aeruginosa 14-19 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45881,,15763244,CHEMBL3637180,Antibacterial activity against Staphylococcus aureus CMCC 26003 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45882,,15763265,CHEMBL3637181,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,4.0
45883,,15763286,CHEMBL3637182,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45884,,15763307,CHEMBL3637183,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-3 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45885,,15763328,CHEMBL3637184,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-4 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45886,,15763349,CHEMBL3637185,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-4 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,16.0
45887,,15763370,CHEMBL3637186,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-5 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45888,,15763391,CHEMBL3637187,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
45889,,15763412,CHEMBL3637320,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-21 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
45890,,15763433,CHEMBL3637321,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-22 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45891,,15764054,CHEMBL3637322,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-37 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45892,,15764075,CHEMBL3637323,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-39 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45893,,15764096,CHEMBL3637324,Antibacterial activity against Streptococcus pneumoniae ATCC 19615 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.015
45894,,15764117,CHEMBL3637325,Antibacterial activity against Enterococcus faecalis 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,32.0
45895,,15764138,CHEMBL3635097,Antibacterial activity against Enterococcus faecalis 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.5
45896,,15764159,CHEMBL3635098,Antibacterial activity against Enterococcus faecium 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
45897,,15764180,CHEMBL3635099,Antibacterial activity against Enterococcus faecium 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,16.0
45898,,15764201,CHEMBL3635100,Antibacterial activity against Enterococcus faecium 14-5 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
45899,,15764222,CHEMBL3635101,Antibacterial activity against Enterococcus faecium 14-6 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,8.0
45900,,15776051,CHEMBL3637162,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
45901,,15776072,CHEMBL3637163,Antibacterial activity against ESBL-positive Escherichia coli 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45902,,15776093,CHEMBL3637164,Antibacterial activity against ESBL-positive Escherichia coli 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45903,,15776114,CHEMBL3637165,Antibacterial activity against Escherichia coli 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
45904,,15776135,CHEMBL3637166,Antibacterial activity against Escherichia coli 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45905,,15776156,CHEMBL3637167,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-17 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
45906,,15776177,CHEMBL3637168,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-18 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
45907,,15776198,CHEMBL3637169,Antibacterial activity against ESBL-positive Klebsiella pneumoniae 14-19 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
45908,,15776219,CHEMBL3637170,Antibacterial activity against Klebsiella pneumoniae 14-1 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
45909,,15776240,CHEMBL3637171,Antibacterial activity against Klebsiella pneumoniae 14-2 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
45910,,15776261,CHEMBL3637172,Antibacterial activity against Klebsiella pneumoniae 14-3 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
45911,,15776282,CHEMBL3637173,Antibacterial activity against Klebsiella pneumoniae 14-4 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
45912,,15776303,CHEMBL3637174,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45913,,15776324,CHEMBL3637175,Antibacterial activity against Pseudomonas aeruginosa 14-9 after 18 to 24 hrs,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3632558,Bioorg Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2511325,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
45914,Not Determined,16410570,CHEMBL3745475,Antibacterial activity against Staphylococcus aureus 1118 infected in sc and iv dosed mouse assessed as septicemia compound administered 1 hr post-infection twice for 1 day measured for 7 days,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3739399,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2738044,,1,0,,PD50,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,PD50,,,
45915,Not Determined,16410605,CHEMBL3745479,Antibacterial activity against methicillin-resistant Staphylococcus aureus 1118 for 18 to 20 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3739399,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2738044,,1,0,,MIC,,,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,,,
45916,,16410606,CHEMBL3745481,Antibacterial activity against Streptococcus pneumoniae for 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3739399,ACS Med Chem Lett,2015.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2738044,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.06
45917,,16413966,CHEMBL3745429,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as inhibition of supercoiling activity using relaxed pBR322 plasmid as substrate after 30 mins,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3739357,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2738465,=,1,1,=,IC50,nM,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,11.2
45918,,16414003,CHEMBL3745430,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3739357,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2738465,=,1,1,=,MIC,nM,2400.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,2.4
45919,,16447540,CHEMBL3758003,Inhibition of Mycobacterium tuberculosis DNA gyrase assessed as inhibition of DNA supercoiling after 30 mins by electrophoresis,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3751721,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,1,http://www.openphacts.org/units/Nanomolar,2745725,=,1,1,=,IC50,nM,11200.0,CHEMBL3430898,Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv),DNA gyrase subunit A/DNA gyrase subunit B,83332.0,,IC50,uM,UO_0000065,11.2
45920,,16448689,CHEMBL3758010,Antimicrobial activity against Mycobacterium tuberculosis H37Rv ATCC 27294 after 28 days by alamar blue assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3751721,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2745725,=,1,1,=,MIC,nM,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.26
45921,,16471644,CHEMBL3766327,"Antimycobacterial activity against Mycobacterium marinum ATCC BAA-535 infected in Zebra fish model assessed as reduction in bacterial load at 5 mg/kg, po administered for 7 days measured after 14 days by MPN assay",F,BAO_0000181,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3763117,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2756857,=,1,0,=,Activity,deltalog10CFU/ml,2.9,CHEMBL614987,Mycobacterium marinum,Mycobacterium marinum,1781.0,,Activity,deltalog10CFU/ml,,2.9
45922,,16471647,CHEMBL3766333,Antimycobacterial activity against nutrient starved Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial load for 7 days measured after 28 days by microplate reader analysis,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3763117,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2756857,=,1,1,=,MIC,ug.mL-1,0.78,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,ug ml-1,UO_0000274,0.78
45923,,16554955,CHEMBL3794984,Antibacterial activity against quinolone-resistant Streptococcus pneumoniae TPS3 after 18 to 24 hrs by broth microdilution method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3792299,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2770359,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,4.0
45924,Not Active,16554991,CHEMBL3795079,"Antibacterial activity against quinolone-resistant Streptococcus pneumoniae TPS3 in rat respiratory tract infection model assessed as decrease in bacterial burden in lung at 100 mg/kg, po bid administered through gavage at 1, 7, 24,31 hrs post infection measured after 48 hrs",F,BAO_0000375,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3792299,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2770359,,1,0,,Activity,,,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,Activity,,,
45925,,16561084,CHEMBL3802071,Antibacterial activity against Staphylococcus aureus CMCC 26003 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45926,,16561102,CHEMBL3802072,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45927,,16561120,CHEMBL3802073,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45928,,16561138,CHEMBL3802074,Antibacterial activity against methicillin-sensitive Staphylococcus aureus 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,<,1,1,<,MIC,ug.mL-1,0.008,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.008
45929,,16561156,CHEMBL3802075,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,12.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,12.0
45930,,16561174,CHEMBL3802076,Antibacterial activity against methicillin-resistant Staphylococcus aureus 14-5 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,8.0
45931,,16561192,CHEMBL3802077,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,32.0
45932,,16561210,CHEMBL3802078,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
45933,,16561228,CHEMBL3802079,Antibacterial activity against methicillin-sensitive Staphylococcus epidermidis 14-6 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,2.0
45934,,16561246,CHEMBL3802080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-22 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45935,,16561264,CHEMBL3803900,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-37 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45936,,16561282,CHEMBL3803901,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis 14-39 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,8.0
45937,,16561300,CHEMBL3803902,Antibacterial activity against Streptococcus pneumoniae ATCC 19615 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,0.015,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.015
45938,,16561318,CHEMBL3803903,Antibacterial activity against Enterococcus faecium 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,32.0
45939,,16561336,CHEMBL3803904,Antibacterial activity against Enterococcus faecium 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,0.5
45940,,16561354,CHEMBL3803905,Antibacterial activity against Enterococcus faecalis 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
45941,,16562255,CHEMBL3803906,Antibacterial activity against Enterococcus faecalis 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,16.0
45942,,16562273,CHEMBL3803907,Antibacterial activity against Enterococcus faecalis 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,8.0
45943,,16578101,CHEMBL3801853,Antibacterial activity against Escherichia coli ATCC 25922 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.06
45944,,16578119,CHEMBL3801854,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,2.0
45945,,16579005,CHEMBL3801855,Antibacterial activity against extended-spectrum beta-lactamase-producing Escherichia coli 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45946,,16579023,CHEMBL3801856,Antibacterial activity against Escherichia coli 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,8.0
45947,,16579041,CHEMBL3802057,Antibacterial activity against Escherichia coli 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,16.0
45948,,16579059,CHEMBL3802058,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-17 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
45949,,16579077,CHEMBL3802059,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-18 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,1.0
45950,,16579095,CHEMBL3802060,Antibacterial activity against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae 14-19 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,64.0
45951,,16579113,CHEMBL3802061,Antibacterial activity against Klebsiella pneumoniae 14-1 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,8.0
45952,,16579131,CHEMBL3802062,Antibacterial activity against Klebsiella pneumoniae 14-2 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
45953,,16579149,CHEMBL3802063,Antibacterial activity against Klebsiella pneumoniae 14-3 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,32.0
45954,,16579167,CHEMBL3802064,Antibacterial activity against Klebsiella pneumoniae 14-4 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,16.0
45955,,16579185,CHEMBL3802065,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,2.0
45956,,16579203,CHEMBL3802066,Antibacterial activity against Pseudomonas aeruginosa 14-9 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
45957,,16579221,CHEMBL3802067,Antibacterial activity against Pseudomonas aeruginosa 14-14 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45958,,16579239,CHEMBL3802068,Antibacterial activity against Pseudomonas aeruginosa 14-15 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45959,,16579257,CHEMBL3802069,Antibacterial activity against Pseudomonas aeruginosa 14-16 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
45960,,16579275,CHEMBL3802070,Antibacterial activity against Pseudomonas aeruginosa 14-19 after 18 to 24 hrs by CLSI M100-S11 method,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3797178,Bioorg Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2772306,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45961,,16607675,CHEMBL3812637,Antibacterial activity against methicillin-susceptible Staphylococcus aureus 42 incubated for 18 to 24 hrs by broth microdilution assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3808315,ACS Med Chem Lett,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2779541,=,1,1,=,MIC,ug.mL-1,0.06,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.06
45962,,16649292,CHEMBL3830493,Antibacterial activity against nutrient-starved dormant Mycobacterium tuberculosis H37Rv assessed in log reduction in bacterial count at 10 ug/ml measured after 7 days by MPN assay relative to control,F,BAO_0000179,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3826950,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2788872,=,1,0,=,FC,,2.8,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,2.8
45963,,16649309,CHEMBL3830494,Antibacterial activity against actively replicative Mycobacterium tuberculosis H37Rv measured after 7 days by MABA assay,F,BAO_0002146,BAO_0000218,organism-based format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3826950,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2788872,=,1,1,=,MIC,nM,1240.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.24
45964,,16672630,CHEMBL3855799,Antimycobacterial activity against Mycobacterium tuberculosis H37Rv after 7 days by MABA,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3853352,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2797270,=,1,1,=,MIC,nM,1260.0,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,MIC,uM,UO_0000065,1.26
45965,,16672664,CHEMBL3855800,Antimycobacterial activity against dormant stage of Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth under nutrient starved conditions at 10 ug/ml for 7 days measured after 28 days,F,BAO_0000179,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3853352,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,,2797270,=,1,0,=,FC,,2.7,CHEMBL360,Mycobacterium tuberculosis,Mycobacterium tuberculosis,1773.0,,FC,,,2.7
45966,,16672733,CHEMBL3855802,Inhibition of Mycobacterium tuberculosis ADH assessed as decrease in conversion of L-alanine to pyruvate by measuring NADH by spectrophotometry,B,BAO_0000190,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3853352,Bioorg Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/Nanomolar,2797270,>,1,1,>,IC50,nM,25000.0,CHEMBL612545,,Unchecked,,,IC50,uM,UO_0000065,25.0
45967,,16743506,CHEMBL3858077,Antibacterial activity against Staphylococcus aureus ATCC 29213 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45968,,16743512,CHEMBL3858078,Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 33592 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL352,Staphylococcus aureus,Staphylococcus aureus,1280.0,,MIC,ug ml-1,UO_0000274,0.25
45969,,16743518,CHEMBL3858079,Antibacterial activity against methicillin-susceptible Staphylococcus epidermidis isolate CANWARD-2008 81388 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,0.25
45970,,16743524,CHEMBL3858080,Antibacterial activity against methicillin-resistant Staphylococcus epidermidis isolate CAN-ICU 61589 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL353,Staphylococcus epidermidis,Staphylococcus epidermidis,1282.0,,MIC,ug ml-1,UO_0000274,64.0
45971,,16743530,CHEMBL3858081,Antibacterial activity against Enterococcus faecalis ATCC 29212 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL362,Enterococcus faecalis,Enterococcus faecalis,1351.0,,MIC,ug ml-1,UO_0000274,0.25
45972,,16743536,CHEMBL3858082,Antibacterial activity against Enterococcus faecium ATCC 27270 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,2.0,CHEMBL357,Enterococcus faecium,Enterococcus faecium,1352.0,,MIC,ug ml-1,UO_0000274,2.0
45973,,16743542,CHEMBL3858083,Antibacterial activity against Streptococcus pneumoniae ATCC 49619 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL347,Streptococcus pneumoniae,Streptococcus pneumoniae,1313.0,,MIC,ug ml-1,UO_0000274,0.25
45974,,16743548,CHEMBL3858084,Antibacterial activity against gentamicin-resistant Escherichia coli isolate CAN-ICU 61714 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,0.5,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,0.5
45975,,16743554,CHEMBL3858085,Antibacterial activity against amikacin-resistant Escherichia coli isolate CAN-ICU 63074 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,1.0
45976,,16743560,CHEMBL3858086,Antibacterial activity against gentamicin/tobramycin/ciprofloxacin-resistant Escherichia coli isolate CANWARD-2011 97615 harboring AAC3-2A after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL354,Escherichia coli,Escherichia coli,562.0,,MIC,ug ml-1,UO_0000274,32.0
45977,,16743566,CHEMBL3858087,Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,4.0
45978,,16743572,CHEMBL3858088,Antibacterial activity against gentamicin-resistant Pseudomonas aeruginosa isolate CAN-ICU 62308 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45979,,16743578,CHEMBL3858089,Antibacterial activity against gentamicin/tobramycin-resistant Pseudomonas aeruginosa isolate CANWARD-2011 96846 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45980,,16743584,CHEMBL3858090,Antibacterial activity against Stenotrophomonas maltophilia isolate CAN-ICU 62584 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,4.0,CHEMBL612366,Stenotrophomonas maltophilia,Stenotrophomonas maltophilia,40324.0,,MIC,ug ml-1,UO_0000274,4.0
45981,,16743590,CHEMBL3858091,Antibacterial activity against Acinetobacter baumannii isolate CAN-ICU 63169 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL614425,Acinetobacter baumannii,Acinetobacter baumannii,470.0,,MIC,ug ml-1,UO_0000274,1.0
45982,,16743596,CHEMBL3858092,Antibacterial activity against Klebsiella pneumoniae ATCC 13883 after 24 hrs by microtitre broth dilution method,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,<=,1,1,<=,MIC,ug.mL-1,0.25,CHEMBL350,Klebsiella pneumoniae,Klebsiella pneumoniae,573.0,,MIC,ug ml-1,UO_0000274,0.25
45983,,16743606,CHEMBL3858093,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 100036,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
45984,,16743618,CHEMBL3858094,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 101885,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,128.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,128.0
45985,,16743630,CHEMBL3858095,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 259-96918,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,512.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,512.0
45986,,16743642,CHEMBL3858096,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 260-97103,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
45987,,16743654,CHEMBL3858097,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 262-101856,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,64.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,64.0
45988,,16743666,CHEMBL3858098,Antibacterial activity against multidrug/extremely drug-resistant/colistin-susceptible Pseudomonas aeruginosa isolate 264-104354,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,32.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,32.0
45989,,16743678,CHEMBL3858099,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 91433,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
45990,,16743690,CHEMBL3858100,Antibacterial activity against pandrug-resistant Pseudomonas aeruginosa isolate 101243,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,8.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,8.0
45991,,16743702,CHEMBL3858101,Antibacterial activity against Pseudomonas aeruginosa PAO1,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,1.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,1.0
45992,,16743710,CHEMBL3858076,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86052,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45993,,16743720,CHEMBL3858102,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86053,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45994,,16743730,CHEMBL3858103,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86067,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45995,,16743740,CHEMBL3858104,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86079,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45996,,16743750,CHEMBL3858105,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 86141,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45997,,16743760,CHEMBL3858106,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 92014,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45998,,16743770,CHEMBL3858107,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 108590,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,=,1,1,=,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
45999,,16743780,CHEMBL3858108,Antibacterial activity against multidrug-resistant/tobramycin-susceptible Pseudomonas aeruginosa isolate 79199,F,BAO_0002146,BAO_0000019,assay format,COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12,CHEMBL3856229,J Med Chem,2016.0,CHEMBL32,MOXIFLOXACIN,CHEMBL32,0,http://www.openphacts.org/units/MicrogramPerMilliliter,2798634,>,1,1,>,MIC,ug.mL-1,16.0,CHEMBL348,Pseudomonas aeruginosa,Pseudomonas aeruginosa,287.0,,MIC,ug ml-1,UO_0000274,16.0
